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Graphical	abstract	
Abstract:	A	highly	 functionalized	 intermediate	 in	 the	 synthesis	of	Taxol	has	been	synthesized,	
which	 features	 the	 tricyclic	 core	and	 the	 required	oxygen	substituents	at	C1,	C2,	C7,	C10	and	
C13.	The	key	step,	a	 ring-closing	dienyne	metathesis	 (RCDEYM)	reaction,	has	been	thoroughly	
optimized	to	favor	the	tricyclic	product	over	the	undesired	bicyclic	product	resulting	from	diene	
metathesis.		
Introduction	
Taxol®	(paclitaxel)	1,	Taxotere®	(docetaxel)	2	and	Jevtana®	(cabazitaxel)	3	are	widely	prescribed	
to	treat	a	broad	range	of	malignancies1	(Scheme	1).	Although	Taxol	 is	produced	through	plant	
cell	 fermentation	 whilst	 Taxotere	 and	 Jevtana	 are	 produced	 by	 semisynthesis	 from	 10-
deacetylbaccatin	 III,	 taxanes	 still	 trigger	 interest	 among	 synthetic	 organic	 chemists,	 as	
exemplified	by	the	formal	syntheses	of	Taxol	recently	reported	by	the	groups	of	Nakada2	as	well	
as	Sato	and	Chida,3	and	the	synthesis	of	decinnamoyltaxinine	E	and	taxabaccatin	III	by	Baran	et	
al.4	 Among	 the	 previous	 syntheses	 of	 Taxol,5	 compound	 4	 reported	 by	 Holton5b	 (Scheme	 1)	
attracted	our	attention.	In	addition	to	being	an	intermediate	en	route	to	Taxol,	it	could	also	be	
rapidly	 transformed	 into	 taxoids	 with	 interesting	 activity;	 indeed,	 it	 has	 been	 shown	 that	 9-
deoxotaxol	exhibits	a	similar	cytotoxicity	to	Taxol	and	10-epi-taxol	and	10-epi-deacetyltaxol	are	
approximately	twice	more	active	than	the	natural	product.6	A	rapid	synthesis	of	the	tricyclic	core	
of	 Taxol	 leading	 to	 Holton's	 intermediate	 would	 pave	 the	 way	 to	 a	 range	 of	 novel	 Taxol	
analogues	with	potential	 anticancer	 activity.	 In	 this	 paper,	we	 report	our	 efforts	 towards	 this	
goal,	with	an	in-depth	study	of	a	cascade	metathesis	reaction	leading	to	the	ABC	tricyclic	core	of	
taxanes.	
Results	and	Discussion	
Our	retrosynthesis	of	Holton's	intermediate	4	is	shown	in	Scheme	1.	The	2-ene-1,4-diol	function	
at	 C10-C13	 would	 be	 formed	 by	 a	 Ti(III)	 radical-mediated	 opening	 of	 the	 corresponding	 1,3-
bisepoxide,	which	can	be	synthesized	by	bis	epoxidation	of	compound	5,7	and	the	ketone	at	C4	
would	be	installed	by	a	hydroboration/oxidation	sequence	of	the	C3-C4	olefin	of	5.5d	Carbonate	
5	 would	 be	 formed	 by	 a	 ring-closing	 dienyne	metathesis	 (RCDEYM)	 reaction	 from	 dienyne	6.	
This	 cascade	metathesis	 reaction	was	 validated	 in	our	previous	work	on	 the	 synthesis	of	 a	7-
deoxy	ABC	tricycle	of	Taxol8	as	well	as	Granja	et	al's	work	on	the	construction	of	simplified	Taxol	
analogues.7b,c	 The	 key	 step	 for	 the	 assembly	 of	 metathesis	 precursors	 is	 a	 Shapiro	 coupling	
reaction	between	aldehyde	8	and	trisylhydrazone	9.	This	reaction	was	shown	to	be	incompatible	
with	 the	presence	of	 an	olefin	at	C10	 in	 the	hydrazone	C	 ring,8b	 so	 the	olefin	at	C10	and	 the	
alcohol	at	C7	were	masked	as	a	methyl	ketal	in	compound	9.9	
Scheme	 1.	 Taxol	 and	 derivatives;	 retrosynthesis	 of	 the	 ABC	 tricycle	 of	 Taxol	 featuring	 a	 ring-
closing	dienyne	metathesis	(RCDEYM).	
	The	synthesis	of	C	ring	9	started	 from	Wieland-Miescher	ketone	10	 (Scheme	2),	which	can	be	
prepared	 on	 large	 scale	 and	 excellent	 enantiomeric	 purity	 using	 the	 method	 described	 by	
Bonjoch	 et	 al.10	 Chemoselective	 and	 diastereoselective	 reduction	 of	 this	 ketone	with	 sodium	
borohydride	at	low	temperature	followed	by	protection	of	the	resulting	alcohol	as	a	triethylsilyl	
ether	 furnished	 compound	 11	 in	 excellent	 yield.	 Decarbonylative	 ozonolysis	 and	 subsequent	
formation	of	the	thioester	proceeded	smoothly	to	give	compound	12	in	good	yield	over	2	steps.	
Thioester	 12	 was	 reduced	 with	 triethylsilane/Pd	 on	 carbon	 and	 the	 resulting	 aldehyde	 was	
treated	with	acid	to	form	lactol	13	as	a	1:1	mixture	of	epimers	after	cleavage	of	the	TES	ether.	
Purdie	 methylation	 of	 compound	 13	 using	 silver(I)	 oxide	 and	methyl	 iodide	 afforded	methyl	
ketal	 14	 as	 a	 single	 diastereomer.	 Finally,	 treatment	 of	 ketone	 14	 with	 trisylhydrazine	 and	
catalytic	HCl	led	to	the	desired	hydrazone	9	in	59%	overall	yield	over	7	steps.	
Scheme	2.	Synthesis	of	C	ring	9.	
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The	aldehyde	coupling	partner	(±)-8	had	been	synthesized	previously	in	7	steps	and	66%	overall	
yield	 from	ethyl	 isobutyrate	and	propargyl	bromide.8	Enantioenriched	8	 (4:1	er)	could	also	be	
prepared	 in	 9	 steps	 and	 33%	overall	 yield,11	 but	 the	 synthesis	 of	 the	 racemate	was	 easier	 to	
perform	on	large	scale,	so	the	Shapiro	coupling	reaction	was	performed	using	(±)-8	(Scheme	3).	
Scheme	3.	Synthesis	of	unprotected	metathesis	precursor	18a.		
	
This	 reaction	 proved	 to	 be	 very	 diastereoselective,	 giving	 only	 the	 trans	 1,2-diols12	 after	
hydrolysis	 of	 the	 trimethylsilyl	 ether,	 as	was	observed	with	 similar	 substrates	 in	 our	 previous	
synthetic	routes	to	taxoids.8,	13	Diastereomer	7	was	transformed	into	carbonate	16,	which	was	
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crystalline,	 and	 X-ray	 crystallographic	 analysis	 confirmed	 that	 it	 possessed	 the	 required	
configuration	for	Taxol	at	C1	and	C2	(See	supporting	information	for	details).14	The	methyl	ketal	
in	16	was	then	hydrolyzed	with	concentrated	sulfuric	acid	and	the	resulting	hemiketal	reduced	
with	 sodium	 borohydride	 to	 furnish	 diol	 17	 in	 excellent	 yield.	 The	 primary	 alcohol	 was	
selectively	 eliminated	 using	 the	 Grieco	 protocol15	 to	 furnish	 the	 unprotected	 metathesis	
precursor	18a.		
To	study	the	cascade	metathesis	reaction	in	detail,	diverse	protecting	groups	were	installed	on	
the	alcohol	at	C7	to	give	compounds	18b-f	(Scheme	4).	Compound	18g	with	a	methyl	ether	at	C7	
was	also	prepared,	as	it	constitutes	an	intermediate	in	the	synthesis	of	Jevtana®	(Scheme	1).		
Scheme	4.	Synthesis	of	diversely	protected	metathesis	precursor	18b-g.	
	
DMAP	 =	 4-dimethylaminopyridine,	 PMB	 =	 pmethoxybenzyl,	 MOM	 =	 methoxymethyl,	 BOM	 =	
benzyloxymethyl,	DMF	=	N,N-dimethylformamide.	
We	 next	 attempted	 to	 perform	 the	 key	 metathesis	 reaction	 on	 compound	 18a	 with	 a	 free	
alcohol	at	C7	under	the	conditions	that	were	optimized	for	the	7-deoxy	derivative	18h	(R	=	H),	
with	the	Zhan-1B	precatalyst	(Table	1).8	Unfortunately,	only	the	bicyclic	compound	20a	resulting	
from	 metathesis	 between	 the	 olefins	 at	 C10	 and	 C13	 was	 obtained,	 along	 with	 a	 complex	
mixture	 of	 side	 products.	 This	 poor	 result	 could	 be	 due	 to	 the	 deactivation	 of	 the	 carbene	
formed	from	the	olefin	at	C10	by	complexation	with	the	hydroxyl	group	at	C7.	When	the	OH	at	
C7	was	protected	as	a	silyl	ether	or	an	acetate,	only	20b,c	were	observed,	albeit	in	good	yields.	
The	compounds	possessing	C7	ether	groups	(OPMB,	OMOM	and	OBOM)	18d-f	gave	the	desired	
products	in	about	30%	yield,	along	with	varying	amounts	of	compounds	20d-f.	The	methyl	ether	
18g	gave	 the	 highest	 yield	 (45%)	of	 the	 desired	 tricycle	19g,	 along	with	 30%	of	20g,	 but	 this	
result	was	disappointing	compared	with	the	70%	yield	obtained	for	the	7-deoxy	compound	19h.	
It	 seems	 that	 small	 substituents	 at	 C7	 (R	 =	 H	 or	 OMe)	 favor	 the	 formation	 of	 the	 tricyclic	
compound;	in	the	case	of	a	larger	R	group,	the	gauche	interaction	between	this	substituent	and	
the	allyl	group	leads	to	a	conformation	of	the	dienyne	in	which	the	carbene	at	C10	is	closer	to	
the	alkene	at	C13	than	the	alkyne	at	C11.16	
Table	1.	Metathesis	reactions	of	compounds	18.[a]	
	
R Substrate Yield of 19a-h (%) Yield of 20a-h (%) 
OH 18a 0 23 
OTES 18b 0 77 
OAc 18c 0 80 
OPMB 18d 29 22 
OMOM 18e 28 54 
OBOM 18f 29 46 
OMe 18g 45 30 
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[a]	Reaction	conditions:	a)	10	mol%	Zhan-1B,	toluene,	110	°C,	12	h.	See	Table	2	for	structure	of	
Zhan-1B	precatalyst.	
In	order	to	optimize	the	yield	of	the	desired	tricycle,	we	revisited	the	metathesis	cascade	of	18f	
(R	=	OBOM)	with	different	precatalysts	(Table	2).	The	Grubbs	2	and	the	Hoveyda-Grubbs	2	(HG2)	
precatalysts	gave	poor	yields	of	the	tricyclic	product	19f,	while	the	Grela	complex	led	to	a	slight	
improvement.	Although	the	overall	yield	is	better	with	the	Grela	catalyst,	the	ratio	of	19f/20f	is	
similar;	 therefore	 all	 the	 subsequent	 experiments	 were	 perfomed	 with	 the	 more	 readily	
available	 precatalyst	 Zhan-1B.	 The	 influence	 of	 the	 solvent	 and	 the	 temperature	 was	 also	
probed	 (Table	 2);	 performing	 the	 metathesis	 reaction	 in	 1,2-dichloroethane	 (DCE)	 at	 reflux	
improved	 the	 overall	 product	 yield	 of	 the	 reaction	 but	 not	 of	 the	 desired	 tricycle,	 while	 the	
reaction	performed	in	xylene	at	reflux	only	produced	33%	of	the	bicycle	20f.	
Table	2.	Metathesis	reactions	of	compound	18f	with	different	precatalysts[a]	
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R = H
R = NO2
R = SO2NMe2
Precatalyst Solvent Yield of 19f (%) Yield of 20f (%) 
Grubbs 2 toluene 12 64 
Hoveyda-Grubbs 2 toluene 17 36 
Grela toluene 33 57 
Zhan-1B toluene 29 46 
Zhan-1B 1,2-dichloroethane 23 63 
Zhan-1B pxylene 0 33 
[a]	Reaction	conditions:	a)	10	mol%	precatalyst,	solvent,	reflux,	16	h.		
The	 different	 results	 observed	 between	 the	 reactions	 with	 the	 Hoveyda-Grubbs-type	
precatalysts	can	only	be	due	to	the	presence	of	the	styrene	derivative	released	after	formation	
of	 the	first	carbene	derived	from	18f.17	To	assess	the	 importance	of	 this	 ligand,	metathesis	of	
18f	 was	 performed	 with	 HG2	 in	 the	 presence	 of	 three	 equivalents	 of	 2-isopropoxystyrene	
(Scheme	 5).	 This	 led	 to	 a	 slight	 improvement	 in	 the	 yields	 of	 both	19f	 and	20f.	 In	 a	 parallel	
experiment,	the	isopropylidene	carbene	was	preformed	by	stirring	the	Zhan-1B	complex	with	2-
methyl-2-butene	 for	 4	 h,18	 and	 when	 18f	 was	 treated	 with	 this	 mixture	 under	 the	 standard	
conditions,	only	3%	of	19f	and	23%	of	20f	were	obtained.	The	exact	roles	of	the	ligand	and	the	
isobutene	released	after	the	second	catalytic	cycle	are	not	clear,	but	clearly	the	presence	of	the	
former	is	beneficial	and	that	of	the	latter	deleterious	to	the	outcome	of	the	metathesis	reaction.	
Scheme	5.	Metathesis	reaction	of	18f	with	added	ligand.		
	With	this	observation	in	mind,	the	next	parameter	we	changed	was	the	amount	of	precatalyst	
used	for	the	reaction.	Increasing	the	amount	of	Zhan-1B	to	100	mol%	did	improve	the	yield	of	
19f,	but	at	the	expense	of	20f	(Table	3).	It	became	clear	that	compound	20f	was	not	very	stable	
under	the	metathesis	reaction	conditions.	This	was	confirmed	by	stirring	a	mixture	of	19f	and	
20f	 with	 10	 mol%	 of	 Zhan-1B	 in	 toluene	 at	 reflux	 for	 16h.	 After	 that	 time,	 the	 tricycle	 was	
recovered	 almost	 entirely	 while	 more	 than	 half	 of	 the	 bicycle	 had	 degraded.	 When	 the	
metathesis	reaction	with	50	or	100	mol%	of	precatalyst	was	stopped	after	45	min,	19f	and	20f	
were	obtained	 in	12-13%	and	58-57%	yield,	 respectively	 (Table	3),	 implying	 that	bicycle	20f	 is	
the	kinetic	product	of	this	reaction	and	that	it	isomerizes	slowly	to	tricycle	19f	(see	Scheme	6	for	
proof	of	isomerization).	Unfortunately,	the	decomposition	of	20f	is	faster	than	its	conversion	to	
19f.	 From	 a	 preparative	 point	 of	 view,	 the	 best	 conditions	 consisted	 of	 stirring	18f	 with	 100	
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mol%	of	Zhan-1B	in	toluene	at	reflux	for	4	h,	which	reliably	gave	35-40%	yield	of	19f,	along	with	
50%	of	recovered	precatalyst.19	
Table	3.	 Influence	of	 catalyst	 loading	and	 reaction	 time	on	 the	outcome	of	 the	metathesis	of	
18f.[a]	
	
X (mol%) Time Yield of 19f (%) Yield of 20f (%) 
10 16 h 29 46 
50 16 h 27 20 
100 16 h 35 traces 
50 45 min 12 58 
100 45 min 13 57 
[a]	Reaction	conditions:	a)	X	mol%	Zhan-1B,	toluene,	110	°C,	Time.	
An	additional	experiment	was	performed	to	confirm	the	isomerization	of	20f	into	19f	during	the	
metathesis	reaction.	After	treating	18f	with	100	mol%	of	Zhan-1B	in	toluene	at	reflux	for	5	h,	at	
which	point	there	is	no	bicycle	remaining	in	the	reaction	mixture,	one	equivalent	of	bicycle	20f	
was	 added	 and	 the	mixture	 was	 stirred	 for	 an	 additional	 12	 h	 (Scheme	 6).	 Tricycle	 19f	 was	
isolated	 in	47%	yield,	 indicating	 that	around	10%	of	20f	 isomerized	to	19f	and	the	rest	of	 the	
bicycle	decomposed.	
Scheme	6.	Metathesis	reaction	of	18f	with	added	20f.		
	The	 beneficial	 influence	 of	 ethylene	 on	 ring-closing	 enyne	metathesis	 (RCEYM)	 is	well	 known	
because	it	helps	release	the	catalyst	at	the	end	of	the	cycle.20	Although	the	presence	of	ethylene	
might	not	be	necessarily	helpful	in	a	cascade	process	where	the	RCEYM	is	followed	by	a	diene	
metathesis	that	achieves	this	release,	 it	could	help	us	identify	 intermediates	in	the	metathesis	
cascade.	Thus,	compound	18f	was	treated	with	10	mol%	of	Zhan-1B	in	toluene	at	reflux	under	
an	ethylene	atmosphere.	A	1:3.5	inseparable	mixture	of	20f	and	21f,	which	encompasses	the	AC	
ring	system	of	Taxol,	was	obtained	in	70%	yield,	along	with	30%	yield	of	22f,	containing	the	BC	
bicycle	 of	 Taxol	 (Scheme	 7).	 When	 20f	 was	 resubmitted	 to	 the	 metathesis	 reaction	 with	
ethylene,21	 it	was	converted	 into	21f	 in	28%	yield,	with	no	trace	of	22f	or	 the	desired	tricycle	
19f.	
Scheme	7.	Metathesis	of	18f	under	ethylene	atmosphere	and	conversion	experiments.		
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	Bicycle	22f	is	the	product	of	simple	RCEYM	of	18f,	which	is	favored	under	ethylene	atmosphere.	
A	possible	mechanism	for	the	formation	of	compound	21f	is	presented	in	Scheme	8.	We	believe	
that	formation	of	20f	occurs	first	by	diene	RCM,	because	the	alkyne	is	hindered.	Ring-opening	
metathesis	 (ROM)	 could	 produce	 carbene	1,	 but	 since	 the	olefin	 at	 C13	 is	 unhindered,	 diene	
RCM	would	occur	 to	 form	again	20f.8	 Reaction	of	 the	methylidene	 carbene	with	20f	 leads	 to	
carbene	 2,	 which	 undergoes	 RCM/ROM	 to	 furnish	 carbene	 3	 (R	 =	 H)	 rather	 than	 carbene	 4,	
featuring	 a	 nine-membered	 ring.	 Carbene	 3	 then	 reacts	 with	 ethylene	 to	 furnish	 21f	 and	
releases	the	catalyst.	When	bicycle	20f	was	submitted	to	Zhan-1b	catalyst	in	the	presence	of	2-
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methyl-2-butene	 to	 regenerate	 the	 carbene	 shown	 in	 Scheme	 5,	 no	 reaction	 occurred	 (see	
Scheme	7),	 suggesting	 that	 the	 isomerization	of	20f	 into	19f	 does	not	 start	with	ROM	of	20f.	
This	 isomerization	 could	 also	 be	 explained	 by	 the	 mechanism	 shown	 in	 Scheme	 8,	 where	
carbene	3	 (R	=	Aryl	 coming	 from	 the	precatalyst)	would	undergo	RCM	 to	 furnish	 tricycle	19f.	
This	RCM	is	very	challenging,	which	explains	the	poor	conversion	of	20f	to	19f	(around	10%	with	
100	mol%	of	precatalyst)	vs	decomposition	(see	Scheme	6).	
Scheme	8.	Possible	mechanism	for	the	formation	of	21f	and	isomerization	of	20f	into	19f.		
	We	 next	 turned	 to	 the	 functionalization	 of	 tricycle	 19f.	 Epoxidation	 with	 one	 equivalent	 of	
mCPBA	selectively	oxidized	 the	more	 reactive	bridgehead	olefin	of	19f	 to	give	23	 in	excellent	
yield	 (Scheme	 9),	 so	 we	 decided	 to	 pursue	 this	 route	 before	 exploring	 the	 bis	 epoxidation	
pathway.	Expecting	that	the	fused	trisubstituted	alkene	at	C3-C4	would	be	more	reactive	than	
the	 other	 trisubstituted	 alkene	 at	 C12-C13,	 we	 next	 submitted	 compound	 23	 to	 a	 range	 of	
standard	 hydroboration	 conditions	 (BH3•THF	 or	 BH3•Me2S),	 but	 to	 our	 surprise	 no	 reaction	
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occurred	 at	 ambient	 temperature	 and	 only	 decomposition	 was	 observed	 under	 forcing	
conditions	(ten	equivalents	of	reagent,	reflux	in	THF).	Compound	23	was	then	transformed	into	
the	corresponding	benzoate	24	by	addition	of	phenyllithium,5b	but	attempted	hydroboration	of	
24	was	equally	unsuccessful.	
Scheme	9.	Functionalization	of	19f.	
	
mCPBA	=	meta-chloroperbenzoic	acid.	
Next,	carbonate	23	was	treated	with	allyl	alcohol	 in	the	presence	of	diverse	acids	to	open	the	
epoxide	 in	 a	 vinylogous	manner.	 No	 reaction	 occurred	 with	 Yb(OTf)3	 and	 in	 the	 presence	 of	
stronger	 Lewis	 acid	 Sc(OTf)3	 or	 Brønsted	 acids	 such	 as	 camphorsulfonic	 acid,	 skeletal	
rearrangement	 took	 place	 to	 give	 aldehyde	 25	 (Scheme	 10).	 Epoxide	 24	 proved	 to	 be	more	
reactive	and	gave	the	desired	allylic	alcohol	26	under	Yb(OTf)3	catalysis.	However,	this	product	
was	 accompanied	 by	 the	 rearranged	 polycyclic	 compound	 27.	 The	 structure	 of	 27	 was	
determined	by	NMR	studies	(see	the	supporting	information	for	details).	
Scheme	10.	Further	functionalization	of	19f.	
O O
O
OBOM
R1O OR2
OBOMO
19f
23 R1= R2 = CO
24 R1= H, R2 = Bz
3
4
12
13
mCPBA (1.2 equiv)
CH2Cl2, 86%
PhLi, THF
92%
	Formation	 of	 polycycle	 27	 can	 be	 explained	 by	 a	 cationic	 cyclization	 cascade	 reaction,	 as	
illustrated	in	Scheme	11.	Opening	of	the	activated	epoxide	forms	carbocation	A,	where	the	C4	
and	 C13	 position	 are	 very	 close	 due	 to	 the	 convex	 shape	 of	 this	 tricycle.	 Cyclization	 of	 A	
between	 these	 two	 positions	 furnishes	 intermediate	 B	 encompassing	 an	 additional	 six-
membered	ring.	Further	cyclization	between	C3	and	C11	leads	to	five-membered	ring	cation	C.	
Finally,	loss	of	proton	and	aqueous	work-up	gives	27.	
Scheme	11.	Possible	mechanism	for	the	formation	of	compound	27.		
	Even	mild	acidic	conditions	such	as	the	3-chlorobenzoic	acid	contained	in	mCPBA	promoted	the	
rearrangement	of	epoxide	24	 into	polycycle	27.	Fortunately,	 treatment	of	compound	19f	with	
excess	 mCPBA	 furnished	 diepoxide	 trans-28	 in	 70%	 yield,	 along	 with	 6%	 of	 the	 minor	
diastereomer	 cis-28	 (Scheme	 12).22	 Radical	 opening	 of	 this	 diepoxide	 using	 the	 conditions	
developed	 by	 Granja	 et	 al.7a	 on	 taxoids	 led	 to	 diol	 29	 in	 only	 19%	 yield	 in	 refluxing	 THF;23	
however,	 the	 same	 reaction	 performed	 on	 the	 corresponding	 benzoate	 30	 at	 ambient	
temperature	gave	diol	31	in	53%	yield.	The	alcohols	at	C10	and	C13	were	easily	differentiated	by	
selective	 silyl	 ether	 formation	 at	 C10,	 but	 hydroboration	 of	 the	 C3-C4	 olefin	was	 once	 again	
unsuccessful.	Under	forcing	conditions,	only	the	C11-C12	alkene	seems	to	react.	
Scheme	12.	Final	functionalization	of	19f.	
	
Conclusions	
In	summary,	we	have	synthesized	an	advanced	intermediate	in	the	synthesis	of	Taxol	with	the	
required	 oxygen	 substituents	 at	 C1,	 C2,	 C7,	 C10	 and	 C13.	 The	 key	 ring-closing	 dienyne	
metathesis	 (RCDEYM)	step	has	been	studied	 in	detail,	but	the	presence	of	a	substituent	at	C7	
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seems	to	favor	the	diene	metathesis	reaction	giving	the	undesired	bicycle	20f	 rather	than	the	
enyne	metathesis	leading	to	the	tricyclic	core	of	Taxol	19f.	Oxygenation	of	this	compound	was	
difficult	 because	 of	 the	 unpredictable	 reactivity	 of	 the	 strained	 tricycle,	 but	we	were	 able	 to	
install	 the	 2-ene-1,4-diol	 function	 at	 C10-C13	with	 the	 required	 configurations	 for	 Taxol.	 The	
poor	reactivity	of	the	C3-C4	olefin	suggests	that	it	will	be	necessary	to	install	the	substituent	at	
C4	before	the	formation	of	the	tricycle	by	cascade	metathesis,	and	we	are	currently	working	on	
this	new	approach.	
Experimental	Section	
General	Remarks.	Reactions	involving	air-sensitive	agents	and	dry	solvents	were	performed	in	
glassware	that	had	been	dried	in	an	oven	(150	°C)	or	flame-dried	prior	to	use.	These	reactions	
were	carried	out	with	the	exclusion	of	air	using	an	argon	atmosphere.	Melting	points	were	
determined	using	a	hot	stage	apparatus	and	are	uncorrected.	Proton	nuclear	magnetic	
resonance	(1H	NMR)	spectra	were	recorded	at	400	MHz/500	MHz	and	13C	NMR	at	100	MHz/126	
MHz.	Chemical	shifts	are	reported	in	ppm.	1H	NMR	spectra	were	recorded	with	CDCl3	as	the	
solvent	using	residual	CHCl3	(δ=	7.27)	as	internal	standard,	and	for	
13C	NMR	spectra	the	
chemical	shifts	are	reported	relative	to	the	central	resonance	of	CDCl3	(δ	=	77.0).	Signals	in	NMR	
spectra	are	described	as	singlet	(s),	doublet	(d),	triplet	(t),	quartet	(q),	quintet	(quint),	septet	
(spt),	multiplet	(m),	broad	(br)	or	combination	of	these,	which	refers	to	the	spin-spin	coupling	
pattern	observed.	Spin-spin	coupling	constants	reported	are	uncorrected.	Two	dimensional	
(COSY,	HSQC,	HMBC,	NOESY)	NMR	spectroscopy	was	used	where	appropriate	to	assist	the	
assignment	of	signals	in	the	1H	and	13C	NMR	spectra.	For	the	description	of	NMR	spectra,	the	
numbering	used	follows	the	chain	extension	or	Taxol	numbering,	not	the	IUPAC	numbering	
rules.	IR	spectra	were	obtained	employing	a	type	IIa	diamond	as	a	single	reflection	element	so	
that	the	IR	spectrum	of	the	compound	(solid	or	liquid)	could	be	detected	directly	(thin	layer).	
High	resolution	mass	spectra	were	recorded	under	(ESI)	(TOF-Q),	(EI)	(Quadrupole)	and	(CI)	
(Quadrupole)	mass	spectrometers.	Flash	column	chromatography	was	performed	using	forced	
flow	of	the	indicated	solvent	system	on	Silica	Gel	60	as	solid	support	and	HPLC	graded	solvents	
as	eluant.	Reactions	were	monitored	by	thin	layer	chromatography	(TLC)	using	silica	gel	60	F254	
precoated	plates.	TLC	plates	were	developed	under	UV-light	and/or	with	an	acidic	ethanolic	
anisaldehyde	solution	or	a	KMnO4	solution.	All	reagents	were	purchased	from	commercial	
suppliers	and	used	without	further	purification	unless	otherwise	stated.	
(4S,5S)-5-Hydroxy-methyl-4,4,5,6,7,8-hexahydronaphthalen-2(3H)-one.	To	a	solution	of	ketone	
10	 (43.3	g,	243	mmol)	 in	 (1:1)	MeOH/CH2Cl2	 (700	mL)	at	 -78	 °C	was	added	NaBH4	 (9.2	g,	243	
mmol,	1.0	equiv).	The	reaction	mixture	was	stirred	for	15	min.	Acetone	(200	mL)	and	H2O	(200	
mL)	 were	 added.	 The	 aqueous	 layer	 was	 extracted	 with	 CH2Cl2	 (200	mL),	 and	 the	 combined	
organic	 extracts	 were	 dried	 over	 anhydrous	MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	
crude	 mixture	 was	 then	 purified	 by	 flash	 chromatography	 (petroleum	 ether/EtOAc:	 6/4)	 to	
afford	 the	 title	 secondary	 alcohol	 (43.8	 g,	 243	mmol,	 100%)	 as	 a	 colourless	oil.	 1H	NMR	 (500	
MHz,	CDCl3)	δ	ppm:	5.79	(d,	J	=	1.9	Hz,	1H),	3.44	(dd,	J	=	11.6,	3.6	Hz,	1H),	2.49-2.30	(m,	3H),	
2.25-2.15	(m,	2H),	1.93-1.81	(m,	4H),	1.77-1.66	(m,	1H),	1.48-1.36	(m,	1H),	1.21	(s,	3H).	13C	NMR	
(126	MHz,	CDCl3)	δ	ppm:	199.5,	168.4,	125.5,	78.3,	41.6,	34.2,	33.7,	32.0,	30.3,	23.1,	15.2.	HRMS	
(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C11H16O2Na	203.1043,	found	203.1043.	[α]
25
D
:	+185	(c	1.5,	
benzene).	
(4S,5S)-4-Methyl-5-((triethylsilyl)oxy)-4,4,5,6,7,8-hexahydronaphthalen-2(3H)-one	 (11).	 To	 a	
solution	of	secondary	alcohol	(43.8	g,	243	mmol)	in	CH2Cl2	(150	mL)	were	added	imidazole	(41.3	
g,	 607	mmol,	 2.5	 equiv)	 and	 TESCl	 (61	mL,	 364	mmol,	 1.5	 equiv).	 The	 reaction	mixture	 was	
stirred	 for	16	h.	A	 saturated	aqueous	 solution	of	NaHCO3	 (100	mL)	was	added	 to	quench	 the	
reaction.	The	aqueous	 layer	was	extracted	with	CH2Cl2	 (3x150	mL),	and	the	combined	organic	
extracts	 were	 washed	 with	 brine	 (300	 mL),	 dried	 over	 anhydrous	 MgSO4,	 filtered	 and	
concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	 chromatography	
(petroleum	ether/Et2O:	9/1	to	7/3)	to	afford	the	title	protected	alcohol	11	(64.4	g,	219	mmol,	
90%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.78	(d,	J	=	1.7	Hz,	1H),	3.40	(dd,	J	=	
10.9,	4.9	Hz,	1H),	2.51-2.27	(m,	3H),	2.19	(ddt,	J	=	14.7,	4.1,	1.9	Hz,	1H),	2.13	(ddd,	J	=	13.6,	5.2,	
3.8	Hz,	1H),	1.89-1.81	(m,	1H),	1.79-1.65	(m,	3H),	1.43-1.30	(m,	1H),	1.18	(s,	3H),	0.97	(t,	J	=	7.9	
Hz,	9H),	0.61	 (q,	 J	=	7.9	Hz,	6H).	 13C	NMR	 (126	MHz,	CDCl3)	δ	ppm:	199.8,	168.9,	125.3,	78.9,	
42.2,	34.6,	33.9,	32.1,	30.8,	23.0,	15.5,	6.9,	5.2.	IR	(ν,	cm-1):	3019,	2960,	1670,	1625,	1460,	1255,	
1100,	 1056.	 HRMS	 (CI/ISO)	 m/z:	 [M+H]+	 Calcd	 for	 C17H31O2Si	 295.2093,	 found	 295.2092.	
[α]
25
D
:	+105	(c	1.0,	CHCl3).	Spect.	Reference:	Ma,	C.;	Schiltz,	S.;	Prunet,	J.	Collect.	Czech.	Chem.	
Commun.	2011,	76,	1579-1594.	
3-((1R,6S)-1-Methyl-2-oxo-6-((triethylsilyl)oxy)cyclohexyl)propanoic	 acid.	 To	 a	 solution	 of	 11	
(5.0	g,	17	mmol)	in	MeOH	(180	mL)	at	-78	°C	was	passed	a	stream	of	O3	for	50	min.	The	reaction	
mixture	 was	 concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	
chromatography	 (petroleum	 ether/Et2O/AcOH:	 75/25/0.1)	 to	 afford	 the	 title	 acid	 (4.7	 g,	 15	
mmol,	88%)	as	a	colourless	oil.	1H	NMR	 (500	MHz,	CDCl3)	δ	ppm:
	 1H	NMR	(500	MHz,	CDCl3)	δ	
10.75	(br	s,	1H),	3.82	(dd,	J	=	6.5,	2.2	Hz,	1H),	2.41-2.32	(m,	3H),	2.23	(ddd,	J	=	16.4,	11.3,	5.1	Hz,	
1H),	2.09-1.96	(m,	3H),	1.88-1.74	(m,	2H),	1.71-1.60	(m,	1H),	1.09	(s,	3H),	0.95	(t,	J	=	8.0	Hz,	9H),	
0.59	(q,	J	=	8.0	Hz,	6H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	214.0,	178.6,	76.5,	54.3,	37.7,	30.1,	
29.0,	29.0,	20.4,	17.6,	6.9,	5.0.	IR	(ν,	cm-1):	3250,	2980,	1740,	1715,	1250,	1058.	HRMS	(ESI/TOF-
Q)	m/z:	[M+Na]+	Calcd	for	C16H30O4SiNa	337.1806,	found	337.1794.	[α]
25
D
:	-10.5	(c	1.0,	CHCl3).	
(S)-Ethyl	 3-((1R,6S)-1-methyl-2-oxo-6-((triethylsilyl)oxy)cyclohexyl)propanethioate	 (12).	 To	 a	
solution	of	acid	(26.1	g,	83.0	mmol)	in	CH2Cl2	(200	mL)	was	added	carbonyl	diimidazole	(17.5	g,	
107	mmol,	1.3	equiv)	and	the	reaction	mixture	was	stirred	for	30	min.	Then	EtSH	(12.0	mL,	166	
mmol,	 2.0	 equiv)	 was	 added.	 The	 reaction	 mixture	 was	 stirred	 for	 16	 h.	 The	 volatiles	 were	
removed	 in	 vacuo	 and	 H2O	 (150	 mL)	 was	 added	 and	 the	 aqueous	 layer	 was	 extracted	 with	
CH2Cl2	(3x150	mL),	and	the	combined	organic	extracts	were	washed	with	brine	(500	mL),	dried	
over	anhydrous	MgSO4,	filtered	and	concentrated	in	vacuo.	The	crude	mixture	was	then	purified	
by	 flash	chromatography	(petroleum	ether/Et2O:	95/5)	 to	afford	the	title	 thioester	12	 (24.6	g,	
68.6	mmol,	83%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	3.83	(dd,	J	=	6.1,	1.8	Hz,	
1H),	2.87	(q,	J	=	7.4	Hz,	2H),	2.55	(ddd,	J	=	15.4,	11.4,	5.3	Hz,	1H),	2.42-2.32	(m,	3H),	2.10-1.98	
(m,	3H),	1.88-1.80	(m,	1H),	1.79-1.72	(m,	1H),	1.72-1.64	(m,	1H),	1.25	(t,	J	=	7.4	Hz,	3H),	1.07	(s,	
3H),	0.95	(t,	J	=	7.9	Hz,	9H),	0.59	(q,	J	=	7.9	Hz,	6H).	13C	NMR	 (126	MHz,	CDCl3)	δ	ppm:	213.7,	
199.2,	76.8,	54.3,	39.1,	37.8,	31.1,	29.0,	23.3,	20.4,	17.6,	14.7,	6.9,	5.0.	IR	(ν,	cm-1):	3057,	2964,	
2912,	 2879,	 1704,	 1692,	 1458,	 1419,	 1272,	 1118,	 1079,	 1018,	 1000.	HRMS	 (ESI/TOF-Q)	m/z:	
[M+Na]+	Calcd	for	C18H34O3NaSSi	381.1890,	found	381.1878.	[α]
25
D
:	-21.1	(c	1.0,	CHCl3).	
(4R,8S)-2-Hydroxy-4-methyloctahydro-5H-chromen-5-one	 (13).	 To	 a	 solution	 of	 thioester	 12	
(24.6	g,	68.6	mmol)	in	CH2Cl2	(150	mL)	were	added	triethylsilane	(21.8	mL,	137	mmol,	2.0	equiv)	
and	 10%	 Pd/C	 (7.5	 g)	 portionwise.	 The	 reaction	 mixture	 was	 stirred	 for	 30	 min.	 Then	 the	
reaction	mixture	was	filtered	through	a	short	pad	of	celite	and	the	solvent	was	concentrated	in	
vacuo.	 The	 crude	 mixture	 was	 dissolved	 in	 THF	 (150	 mL)	 and	 at	 0	 °C	 was	 slowly	 added	 an	
aqueous	solution	of	7%	HBr	(150	mL).	The	resulting	mixture	was	stirred	at	this	temperature	for	
1h.	A	saturated	aqueous	solution	of	NaHCO3	(500	mL)	was	slowly	added	to	quench	the	reaction,	
the	aqueous	 layer	was	extracted	with	EtOAc	 (3x500	mL),	 the	combined	organic	extracts	were	
dried	over	anhydrous	MgSO4,	 filtered	and	concentrated	 in	vacuo.	The	crude	mixture	was	then	
purified	by	flash	chromatography	(petroleum	ether/EtOAc:	7/3	to	0/1)	to	afford	the	title	hemi-
acetal	13	as	a	1:1	mixture	of	diastereomers	(12.6	g,	68.6	mmol,	100%)	as	a	colourless	solid.	1H	
NMR	(500	MHz,	CDCl3)	δ	ppm:	5.26	(t,	J	=	3.2	Hz,	0.5H),	4.74	(ddd,	J	=	9.5,	6.5,	2.7	Hz,	0.5H),	4.03	
(dd,	J	=	11.9,	4.1	Hz,	0.5H),	3.38	(dd,	J	=	11.5,	4.2	Hz,	0.5H),	2.97	(br.	s,	0.5H),	2.67	(td,	J	=	14.4,	
7.1	Hz,	1H),	2.40	 (br	s,	0.5H),	2.26-2.16	 (m,	1H),	2.06-1.68	 (m,	6H),	1.66-1.50	 (m,	2H),	1.27	 (s,	
1.5H),	1.23	(s,	1.5H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	213.6,	97.0,	91.5,	79.5,	71.7,	48.6,	48.4,	
36.5,	29.3,	29.0,	26.0,	25.9,	24.7,	20.8,	16.3,	15.3.	 IR	 (ν,	 cm-1):	3425,	2947,	2877,	1705,	1450,	
1373,	 1049,	 964,	 902.	HRMS	 (EI)	 m/z:	 [M]+	 Calcd	 for	 C10H16O3	 184.1099,	 found	 184.1102.	
Spect.	Reference:	Ma,	C.;	Schiltz,	S.;	Prunet,	J.	Collect.	Czech.	Chem.	Commun.	2011,	76,	1579-
1594.	
(2S,4R,8S)-2-Methoxy-4-methyloctahydro-5H-chromen-5-one	(14).	To	a	solution	of	hemi-acetal	
13	(12.6	g,	68.6	mmol)	in	CH2Cl2	(100	mL)	were	added	Ag2O	(17.5	g,	75.5	mmol,	1.1	equiv)	and	
MeI	 (12.8	 mL,	 206	 mmol,	 3.0	 equiv).	 The	 reaction	 mixture	 was	 stirred	 for	 16	 h.	 Then	 the	
reaction	mixture	was	filtered	and	the	solvent	was	concentrated	in	vacuo.	The	crude	mixture	was	
then	purified	by	flash	chromatography	(petroleum	ether/Et2O:	8/2)	to	afford	the	title	acetal	14	
(12.2	g,	61.7	mmol,	90%)	as	a	white	foam.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:
	4.29	(dd,	J	=	9.7,	2.3	
Hz,	1H),	3.50	(s,	3H),	3.32	(dd,	J	=	11.6,	4.1	Hz,	1H),	2.66	(td,	J	=	14.4,	7.0	Hz,	1H),	2.23-2.13	(m,	
1H),	2.04-1.96	 (m,	1H),	1.96-1.88	 (m,	1H),	1.88-1.82	 (m,	1H),	1.81-1.69	 (m,	3H),	1.67-1.58	 (m,	
1H),	1.58-1.48	(m,	1H),	1.24	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	213.7,	104.0,	79.3,	56.5,	
48.7,	36.5,	29.3,	27.3,	26.0,	20.9,	16.3.	IR	(ν,	cm-1):	2854,	2747,	2641,	1736,	1431,	1337,	1264,	
1247,	 1080,	 984,	 953.	 HRMS	 (CI/ISO)	 m/z:	 [M+H]+	 Calcd	 for	 C11H19O3	 199.1334,	 found	
199.1331.	 [α]
25
D
:	 +100	 (c	 1.5,	 CHCl3).	 Spect.	 Reference:	Ma,	 C.;	 Schiltz,	 S.;	 Prunet,	 J.	 Collect.	
Czech.	Chem.	Commun.	2011,	76,	1579-1594.	
2,4,6-Triisopropyl-N'-((2S,4S,8S)-2-methoxy-4-methyloctahydro-5H-chromen-5-
ylidene)benzenesulfonohydrazide	(9).	To	a	solution	of	acetal	14	(14.5	g,	73.2	mmol)	in	THF	(100	
mL)	were	added	TrisNHNH2	(23.8	g,	80.5	mmol,	1.1	equiv)	and	concentrated	HCl	(4	drops).	The	
reaction	mixture	was	 stirred	 for	 3	 h.	 A	 saturated	 aqueous	 solution	 of	 NaHCO3	 (150	mL)	was	
added	to	the	reaction,	the	aqueous	layer	was	extracted	with	Et2O	(3x150	mL),	and	the	combined	
organic	extracts	were	washed	with	brine	 (250	mL),	dried	over	anhydrous	MgSO4,	 filtered	and	
concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	 chromatography	
(petroleum	ether/Et2O:	8/2)	to	afford	the	title	hydrazone	9	(35.0	g,	73.2	mmol,	100%)	as	a	white	
foam.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	7.30	(s,	1H),	7.16	(s,	2H),	4.22	(dd,	J	=	8.6,	3.2	Hz,	1H),	
4.16	(spt,	J	=	6.8	Hz,	2H),	3.47	(s,	3H),	3.13	(dd,	J	=	9.9,	5.9	Hz,	1H),	2.92	(spt,	J	=	6.9	Hz,	1H),	
2.51-2.45	(m,	1H),	2.00	(dd,	J	=	13.7,	6.3	Hz,	1H),	1.96-1.88	(m,	1H),	1.75-1.68	(m,	2H),	1.63-1.53	
(m,	4H),	1.40-1.30	(m,	1H),	1.27	(d,	J	=	6.8	Hz,	6H),	1.26	(d,	J	=	6.9	Hz,	6H),	1.25	(d,	J	=	6.8	Hz,	
6H),	 1.03	 (s,	 3H).	 13C	NMR	 (126	MHz,	CDCl3)	 δ	ppm:	161.8,	153.2,	151.1,	131.2,	123.5,	104.0,	
79.4,	56.4,	42.1,	34.2,	31.3,	29.9,	27.5,	26.1,	24.8,	24.7,	23.6,	23.5,	21.5,	21.5,	17.3.	IR	(ν,	cm-1):	
3240,	 2954,	 2872,	 2836,	 2752,	 2635,	 1712,	 1629,	 1596,	 1550,	 1453,	 1384,	 1326,	 1252,	 1203,	
1160,	1067,	912.	HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C26H42N2O4SNa	478.2865,	found	
478.2867.	[α]
29
D
:	+36.0	(c	1.0,	CHCl3).	
((2S,4S,8S)-2-Methoxy-4-methyl-3,4,4,7,8,8-hexahydro-2H-chromen-5-yl)-5-methyl-2-(2-
methylpent-3-yn-2-yl)hex-4-ene-1,2-diol	 (15)	 and	 (7).	 To	 a	 solution	 of	 hydrazone	 9	 (24	 g,	 50	
mmol,	1.2	equiv)	in	THF	(60	mL)	at	-78	°C	was	added	dropwise	tBuLi	(68	mL,	1.47	M	in	hexane,	
100	mmol,	2.4	equiv).	The	solution	turned	dark	red.	The	solution	was	stirred	at	this	temperature	
for	 30	 min	 and	 warmed	 for	 a	 few	min	 to	 room	 temperature	 and	 intense	 nitrogen	 bubbling	
occured.	The	mixture	was	then	cooled	down	to	–78	°C	and	a	solution	of	aldehyde	(±)-8	(12	g,	42	
mmol)	in	THF	(30	mL)	was	added.	The	resulting	mixture	was	stirred	at	-78	°C	for	5	h	and	became	
yellow.	 The	 reaction	 was	 quenched	 with	 saturated	 aqueous	 NaHCO3	 (100	mL).	 The	 aqueous	
layer	was	extracted	with	Et2O	(3x150	mL),	and	the	combined	organic	extracts	were	washed	with	
brine	 (500	mL),	 dried	 over	 anhydrous	MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	
mixture	was	dissolved	in	THF	(150	mL)	and	a	1N	aqueous	solution	of	HCl	(63	mL,	63	mmol,	1.5	
equiv)	was	 then	added.	 The	 resulting	mixture	was	 stirred	at	 room	 temperature	 for	12	h.	 The	
reaction	 was	 quenched	 with	 saturated	 aqueous	 NaHCO3	 (100	 mL).	 The	 aqueous	 layer	 was	
extracted	with	EtOAc	(3x200	mL),	and	the	combined	organic	extracts	were	washed	with	brine	
(250	mL),	dried	over	anhydrous	MgSO4,	filtered	and	concentrated	 in	vacuo.	The	crude	mixture	
was	then	purified	by	flash	chromatography	(CH2Cl2/EtOAc:	97/3	to	9/1)	to	afford	the	title	diol	15	
(5.7	 g,	 15	mmol,	 35%)	 and	 the	 title	 compound	 7	 (5.7	 g,	 15	mmol,	 35%)	 as	 colourless	 highly	
viscous	oils.	
(1R,2R)-1-((2S,4S,8S)-2-Methoxy-4-methyl-3,4,4,7,8,8-hexahydro-2H-chromen-5-yl)-5-methyl-
2-(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol	(15).	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	6.10	(t,	J	=	
3.7	Hz,	1H),	5.37-5.29	(m,	1H),	4.41	(d,	J	=	4.8	Hz,	1H),	4.39-4.30	(m,	1H),	3.53	(s,	3H),	3.34	(dd,	J	
=	10.7,	5.2	Hz,	1H),	3.11-3.04	(m,	2H),	2.36	(d,	J	=	6.8	Hz,	2H),	2.26-2.16	(m,	2H),	2.00-1.91	(m,	
1H),	1.81	(s,	3H),	1.78-1.69	(m,	5H),	1.7	(d,	J	=	1.0	Hz,	3H),	1.58	(s,	3H),	1.30	(s,	3H),	1.28	(s,	3H),	
1.13	 (s,	 3H).	 13C	NMR	 (126	MHz,	CDCl3)	 δ	 ppm:	 143.7,	 131.7,	 126.4,	 120.7,	 104.0,	 86.4,	 79.2,	
79.0,	78.1,	70.7,	56.3,	41.7,	37.0,	33.0,	32.7,	27.9,	26.2,	26.0,	26.0,	24.8,	23.4,	18.9,	17.9,	3.6.	IR	
(ν,	 cm-1):	 3053,	 2984,	 2956,	 2305,	 1421,	 1265,	 1165,	 1072.	 HRMS	 (EI)	 m/z:	 [M]+	 Calcd	 for	
C24H38O4	390.2770,	found	390.2766.	[α]
26
D
:	-27.6	(c	1.0,	CHCl3).	
(1S,2S)-1-((2S,4S,8S)-2-Methoxy-4-methyl-3,4,4,7,8,8-hexahydro-2H-chromen-5-yl)-5-methyl-2-
(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol	(7).	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.99	(t,	J	=	3.8	
Hz,	1H),	5.40-5.30	(m,	1H),	4.43	(d,	J	=	4.6	Hz,	1H),	4.35	(dd,	J	=	8.7,	3.8	Hz,	1H),	3.52	(s,	3H),	3.34	
(dd,	J	=	12.1,	4.0	Hz,	1H),	3.20	(s,	1H),	2.90	(d,	J	=	4.6	Hz,	1H),	2.31	(dd,	J	=	15.6,	7.0	Hz,	1	H)	2.42	
(dd,	J	=	15.6,	6.8	Hz,	1	H),	2.26-2.18	(m,	2H),	1.89	(dt,	J	=	12.6,	3.6	Hz,	1H),	1.81-1.68	(m,	4H),	
1.79	(s,	3H),	1.71	(d,	J	=	1.1	Hz,	3H),	1.59	(s,	3H),	1.47	(td,	J	=	12.5,	5.7	Hz,	1H),	1.29	(s,	3H),	1.27	
(s,	3H),	1.22	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	146.2,	131.5,	126.2,	121.2,	103.8,	86.6,	
78.7,	78.3,	78.2,	69.5,	56.3,	41.8,	37.5,	33.4,	32.5,	28.1,	26.3,	26.2,	26.1,	24.6,	23.5,	19.9,	18.1,	
3.6.	 IR	 (ν,	 cm-1):	 3245,	 3054,	 2984,	 2305,	 1868,	 1717,	 1669,	 1557,	 1421,	 1265,	 1065.	 	HRMS	
(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C24H38O4Na	413.2662,	found	413.2655.	[α]
25
D
:	-44.0	(c	1.0,	
CHCl3).	
(4S,5S)-5-((2S,4S,8S)-2-Methoxy-4-methyl-3,4,4,7,8,8-hexahydro-2H-chromen-5-yl)-4-(3-
methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	(16).	To	a	solution	of	diol	7	
(6.5	g,	17	mmol)	in	DMF	(250	mL)	was	added	sodium	hydride	(2	g,	60%	in	mineral	oil,	50	mmol,	
3	equiv)	 and	 carbonyl	diimidazole	 (11	g,	 67	mmol,	 4	equiv).	 The	mixture	was	 stirred	at	 room	
temperature	 for	30	min.	The	 reaction	was	quenched	with	saturated	aqueous	NH4Cl	 (150	mL).	
The	aqueous	layer	was	extracted	with	Et2O	(3x150	mL),	and	the	combined	organic	extracts	were	
washed	with	brine	(2x350	mL),	dried	over	anhydrous	MgSO4,	filtered	and	concentrated	in	vacuo.	
The	crude	mixture	was	 then	purified	by	 flash	chromatography	 (petroleum	ether/Et2O:	8/2)	 to	
afford	the	title	carbonate	16	(6.2	g,	15	mmol,	90%)	as	a	colourless	crystalline	solid.	M.p.:	120	°C.	
1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.64	(dd,	J	=	4.8,	2.9	Hz,	1H),	5.36-5.29	(m,	1H),	5.15	(s,	1H),	
4.37	(dd,	J	=	9.6,	2.8	Hz,	1H),	3.53	(s,	3H),	3.37	(dd,	J	=	10.7,	5.6	Hz,	1H),	2.75-2.62	(m,	2H),	2.40-
2.21	(m,	2H),	2.02	(ddd,	J	=	12.8,	4.4,	2.8	Hz,	1H),	1.85-1.66	(m,	4H),	1.76	(s,	3H),	1.72	(d,	J	=	1.2	
Hz,	3H),	1.62	(s,	3H),	1.45	(td,	J	=	13.2,	4.4	Hz,	1H),	1.31	(m,	6H),	1.22	(s,	3H).	13C	NMR	(126	MHz,	
CDCl3)	δ	ppm:	155.0,	140.2,	132.8,	129.5,	118.8,	103.7,	90.0,	83.1,	79.7,	79.1,	77.9,	56.3,	41.2,	
37.3,	32.4,	31.4,	28.0,	26.0,	25.0,	24.8,	24.5,	23.1,	19.5,	18.2,	3.5.	IR	(ν,	cm-1):	3055,	2954,	2857,	
2239,	1793,	1450,	1373,	1327,	1265,	1180,	1118,	1056.	HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	
for	C25H36O5Na	439.2455,	found	439.2455.	[α]
26
D
:	-27.0	(c	1.0,	CHCl3).	
(4S,5S)-5-((4S,8S)-2-Hydroxy-4-methyl-3,4,4,7,8,8-hexahydro-2H-chromen-5-yl)-4-(3-
methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one.	To	a	solution	of	carbonate	
16	(6.2	g,	15	mmol)	in	acetone	(200	mL)	was	added	H2O	(100	mL)	followed	by	slow	addition	of	
H2SO4	conc.	(26	mL,	0.52	mol,	35	equiv).	The	reaction	mixture	was	stirred	at	room	temperature	
for	16	h.	The	 reaction	was	quenched	with	 saturated	aqueous	NaHCO3	 (250	mL).	The	aqueous	
layer	was	extracted	with	EtOAc	(3x250	mL),	and	the	combined	organic	extracts	were	dried	over	
anhydrous	MgSO4,	filtered	and	concentrated	 in	vacuo.	The	crude	mixture	was	then	purified	by	
flash	 chromatography	 (petroleum	 ether/EtOAc:	 7/3)	 to	 afford	 the	 title	 hemiacetal	 as	 a	 1:1	
mixture	of	diastereomers	(5.7	g,	14	mmol,	94%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	
ppm:	5.67-5.60	(m,	1H),	5.34-5.26	(m,	1.5H),	5.14	(s,	1H),	4.80	(ddd,	J	=	9.4,	6.3,	2.8	Hz,	0.5H),	
4.09	(dd,	J	=	12.5,	3.9	Hz,	0.5H),	3.42	(dd,	J	=	11.3,	4.8	Hz,	1H),	2.76-2.60	(m,	2.5H),	2.37-2.19	(m,	
2H),	2.06-1.93	(m,	1H),	1.80-1.63	(m,	4.5H),	1.76	(s,	1.5H),	1.75	(s,	1.5H),	1.71-1.69	(m,	3H)	1.61	
(s,	 1.5H),	 1.60	 (s,	 1.5H),	 1.46	 (td,	 J	 =	 13.3,	 4.7	Hz,	 0.5H),	 1.30	 (m,	6H),	 1.22	 (s,	 1.5H),	 1.19	 (s,	
1.5H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.1,	154.9,	140.4,	140.1,	133.0,	132.9,	129.5,	129.3,	
118.7,	118.6,	96.8,	91.4,	90.2,	90.1,	83.1,	83.0,	79.7,	79.6,	79.1,	78.9,	78.2,	70.2,	41.2,	41.1,	37.3,	
37.0,	32.3,	31.4,	31.3,	29.8,	27.8,	26.4,	26.0,	25.9,	25.0,	25.0,	24.8,	24.8,	24.5,	24.4,	23.2,	23.0,	
19.4,	 18.4,	 18.2,	 18.2,	 3.5,	 3.5.	 IR	 (ν,	 cm-1):	 3393,	 3055,	 2985,	 2848,	 2305,	 1791,	 1650,	 1551,	
1481,	1335,	1272,	1187,	1033.	HRMS	(CI/ISO)	m/z:	[M+H]+	Calcd	for	C24H35O5	403.2484,	found	
403.2482.	
(4S,5S)-5-((5S,6S)-5-Hydroxy-6-(3-hydroxypropyl)-6-methylcyclohex-1-en-1-yl)-4-(3-methylbut-
2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	(17).	To	a	solution	of	hemiacetal	 (5.7	
g,	 14	mmol)	 in	 (1:1)	MeOH/CH2Cl2	 (200	mL)	 at	 0	 °C	 was	 added	 NaBH4	 (1.6	 g,	 42	mmol,	 3.0	
equiv).	The	reaction	mixture	was	allowed	to	reach	room	temperature	and	stir	for	2	h.	Acetone	
(50	mL)	and	H2O	(50	mL)	were	added.	The	aqueous	layer	was	extracted	with	EtOAc	(3x100	mL),	
and	the	combined	organic	extracts	were	dried	over	anhydrous	MgSO4,	filtered	and	concentrated	
in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	 chromatography	 (petroleum	
ether/EtOAc:	5/5	to	0/1)	to	afford	the	diol	17	(5.3	g,	13	mmol,	95%)	as	a	colourless	oil.	1H	NMR	
(500	MHz,	CDCl3)	δ	ppm:	5.81	(t,	J	=	3.9	Hz,	1H),	5.35-5.26	(m,	2H),	3.84	(br	d,	J	=	4.7	Hz,	1H),	
3.67-3.56	(m,	2H),	2.72	(dd,	J	=	16.1,	6.0	Hz,	1H),	2.62	(dd,	J	=	16.1,	7.3	Hz,	1H),	2.35-2.24	(m,	
1H),	2.23-2.13	(m,	1H),	1.90-1.83	(m,	1H),	1.81	(s,	3H),	1.79-1.74	(m,	1H),	1.73-1.68	(m,	1H),	1.70	
(d,	J	=	0.9	Hz,	3H),	1.64	(br	s,	1H),	1.60-1.52	(m,	4H,	2H9),	1.58	(s,	3H),	1.31	(s,	3H),	1.30	(s,	3H),	
1.23	 (s,	 3H).	 13C	NMR	 (126	MHz,	CDCl3)	 δ	 ppm:	 154.9,	 138.5,	 132.7,	 130.5,	 118.9,	 90.0,	 82.9,	
81.8,	79.5,	71.5,	63.3,	41.9,	41.8,	35.4,	31.0,	26.8,	25.8,	24.9,	24.8,	24.7,	22.0,	20.4,	18.1,	3.6.	
HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C24H36O5Na	427.2455,	found	427.2440.	[α]
22
D
:	-12.5	
(c	1.0,	CHCl3).	
(4S,5S)-5-((5S,6S)-6-Allyl-5-hydroxy-6-methylcyclohex-1-en-1-yl)-4-(3-methylbut-2-en-1-yl)-4-
(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	(18a).	To	a	solution	of	diol	17	(1.0	g,	2.5	mmol)	in	
THF	 (70	mL)	was	 added	o-nitrophenylselenocyanate	 (680	mg,	 3.0	mmol,	 1.2	 equiv)	 and	 tri-n-
butylphosphine	 (0.78	mL,	3.0	mmol,	1.2	equiv).	The	mixture	was	stirred	at	 room	temperature	
for	20	min.	The	reaction	was	quenched	with	water	 (10	mL).	The	aqueous	 layer	was	extracted	
with	Et2O	(3x15	mL)	and	the	combined	organic	extracts	were	washed	with	brine	(50	mL),	dried	
over	 MgSO4,	 filtered	 and	 concentrated	 in	 vacuo	 to	 give	 a	 brown	 oil	 that	 was	 used	 without	
further	 purification.	 A	 solution	 of	 (NH4)6Mo7O24.4H2O	 (90	mg)	 in	water	 (7	mL)	 and	 hydrogen	
peroxide	 (2.9	 mL,	 30%	 solution)	 was	 then	 prepared.	 This	 solution	 was	 added	 at	 -15	 °C	 to	 a	
solution	of	the	previous	compound	in	THF	(60	mL).	The	mixture	was	stirred	at	this	temperature	
for	20	min.	The	reaction	was	diluted	with	water	(60	mL).	The	aqueous	layer	was	extracted	with	
EtOAc	(3x60	mL),	and	the	combined	organic	extracts	were	washed	with	brine	(2x150	mL),	dried	
over	anhydrous	MgSO4,	filtered	and	concentrated	in	vacuo.	The	crude	mixture	was	then	purified	
by	 flash	chromatography	 (petroleum	ether/EtOAc:	8/2)	 to	afford	 the	 title	alcohol	18a	 (0.87	g,	
2.25	mmol,	90%)	as	a	pale	yellow	viscous	oil.	1H	NMR	 (500	MHz,	CDCl3)	δ	ppm:	5.94-5.83	(m,	
1H),	5.81	(t,	J	=	4.0	Hz,	1H),	5.36-5.29	(m,	2H),	5.18-5.08	(m,	2H),	3.81	(ddd,	J	=	8.2,	5.7,	2.8	Hz,	
1H),	2.77	(dd,	J	=	15.5,	6.2	Hz,	1H),	2.68	(dd,	J	=	15.5,	7.1	Hz,	1H),	2.54	(dd,	J	=	14.2,	6.7	Hz,	1H),	
2.35-2.13	(m,	3H),	1.89-1.80	(m,	1H),	1.77	(s,	3H),	1.75-1.69	(m,	1H),	1.71	(d,	J	=	1.1	Hz,	3H)	1.62	
(br	s,	1H),	1.60	(s,	3H),	1.33-1.29	(s,	6H),	1.24	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.0,	
138.8,	134.7,	132.6,	131.1,	118.9,	118.1,	89.8,	83.0,	81.0,	79.8,	72.4,	43.7,	42.7,	41.8,	31.2,	25.9,	
24.9,	24.9,	24.6,	22.5,	19.7,	18.1,	3.5.	 IR	 (ν,	 cm-1):	3220,	3054,	2985,	2306,	1792,	1550,	1412,	
1265,	1040.	HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C24H34O4Na	409.2349,	found	409.2331.	
[α]
24
D
:	-29.0	(c	1.0,	CHCl3).	
(4S,5S)-5-((5S,6S)-6-Allyl-6-methyl-5-((triethylsilyl)oxy)cyclohex-1-en-1-yl)-4-(3-methylbut-2-
en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	(18b).	To	a	solution	of	alcohol	18a	(150	
mg,	0.39	mmol)	in	CH2Cl2	(3	mL)	were	added	imidazole	(66	mg,	0.97	mmol,	2.5	equiv),	DMAP	(5	
mg,	0.04	mmol,	0.1	equiv)	and	TESCl	 (98	µL,	0.58	mmol,	1.5	equiv).	The	reaction	mixture	was	
stirred	 for	 16	 h.	 A	 saturated	 aqueous	 solution	 of	 NaHCO3	 (10	mL)	was	 added	 to	 quench	 the	
reaction.	 The	 aqueous	 layer	was	 extracted	with	 CH2Cl2	 (3x10	mL),	 and	 the	 combined	 organic	
extracts	 were	 washed	 with	 brine	 (25	 mL),	 dried	 over	 anhydrous	 MgSO4,	 filtered	 and	
concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	 chromatography	
(petroleum	ether/Et2O:	95/5)	 to	afford	 the	 title	protected	alcoholol	18b	 (195	mg,	0.39	mmol,	
100%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.82-5.68	(m,	2H),	5.37-5.27	(m,	2H),	
5.09-5.00	(m,	2H),	3.80	(dd,	J	=	6.7,	2.3	Hz,	1H),	2.84-2.74	(m,	1H),	2.62	(dd,	J	=	16.3,	8.2	Hz,	1H),	
2.47	(dd,	J	=	14.5,	7.0	Hz,	1H),	2.33-2.21	(m,	1H),	2.17	(dd,	J	=	14.5,	7.6	Hz,	1H),	2.07	(ddt,	J	=	
18.5,	6.3,	4.6	Hz,	1H),	1.87-1.80	(m,	1H),	1.78	(s,	3H),	1.69	(s,	3H),	1.67-1.61	(m,	1H),	1.60	(s,	3H),	
1.28	(s,	3H),	1.28	(s,	3H),	1.16	(s,	3H),	0.94	(t,	J	=	8.0	Hz,	9H),	0.57	(q,	J	=	8.0	Hz,	6H).	13C	NMR	
(126	MHz,	CDCl3)	δ	ppm:	155.1,	138.4,	134.3,	132.0,	130.4,	119.5,	117.5,	90.0,	83.0,	82.8,	79.4,	
72.4,	 43.8,	 42.5,	 42.0,	 31.1,	 25.8,	 25.4,	 24.8,	 24.5,	 22.2,	 20.7,	 18.1,	 7.0,	 5.2,	 3.6.	 IR	 (ν,	 cm-1):	
3054,	2955,	2877,	2350,	1792,	1457,	1412,	1280,	1010.	HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	
for	C30H48O4NaSi	523.3214,	found	523.3192.	[α]
25
D
:	-20.0	(c	1.0,	CHCl3).	
(1S,2S)-2-Allyl-2-methyl-3-((4S,5S)-5-(3-methylbut-2-en-1-yl)-5-(2-methylpent-3-yn-2-yl)-2-oxo-
1,3-dioxolan-4-yl)cyclohex-3-en-1-yl	 acetate	 (18c).	 To	 a	 solution	 of	 alcohol	 18a	 (40	mg,	 0.10	
mmol)	in	CH2Cl2	(2	mL)	were	added	Et3N	(98	µL,	0.7	mmol,	7.0	equiv),	DMAP	(1.0	mg,	10	µmol,	
0.1	equiv)	and	Ac2O	(47	µL,	0.50	mmol,	5.0	equiv).	The	resulting	mixture	was	allowed	to	stir	for	
4	h	at	room	temperature.	A	saturated	solution	of	NaHCO3	(5	mL)	was	added	and	the	aqueous	
layer	was	extracted	with	CH2Cl2	(3x5	mL),	and	the	combined	organic	extracts	were	washed	with	
a	 saturated	aqueous	solution	of	CuSO4	 (5	mL),	brine	 (2x10	mL),	dried	over	anhydrous	MgSO4,	
filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	
chromatography	(petroleum	ether/Et2O:	9/1)	to	afford	the	protected	alcohol	18c	(43	mg,	0.10	
mmol,	100%)	as	a	colourless	oil.1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.84-5.70	(m,	2H),	5.37-5.28	
(m,	2H),	5.12-5.02	(m,	2H),	4.99	(dd,	J	=	6.6,	2.7	Hz,	1H),	2.76	(dd,	J	=	16.3,	6.0	Hz,	1H),	2.66	(dd,	J	
=	16.3,	7.5	Hz,	1H),	2.45	(dd,	J	=	14.3,	6.6	Hz,	1H),	2.26-2.14	(m,	3H),	2.01	(s,	3H),	1.91-1.78	(m,	
2H),	1.77	(s,	3H),	1.70	(d,	J	=	0.9	Hz,	3H),	1.60	(s,	3H),	1.30	(s,	6H),	1.20	(s,	3H).	13C	NMR	 (126	
MHz,	CDCl3)	δ	ppm:	170.5,	154.9,	138.1,	133.2,	132.5,	130.9,	118.9,	118.3,	89.8,	83.0,	81.4,	79.7,	
74.4,	43.8,	41.9,	40.8,	31.2,	25.8,	24.8,	24.5,	22.1,	22.0,	21.1,	20.2,	18.1,	3.5.	IR	(ν,	cm-1):	3054,	
2986,	 2439,	 1792,	 1731,	 1427,	 1265,	 1041.	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	
C26H36O5Na	451.2455,	found	451.2439.	[α]
26
D
:	-2.0	(c	2.0,	CHCl3).		
(4S,5S)-5-((5S,6S)-6-Allyl-5-((4-methoxybenzyl)oxy)-6-methylcyclohex-1-en-1-yl)-4-(3-
methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	 (18d).	 To	 a	 solution	 of	
alcohol	18a	(0.10	g,	0.26	mmol)	in	CH2Cl2	(5	mL)	were	added	PMB-trichloroacetimidate	(0.22	g,	
0.78	 mmol,	 3.0	 equiv)	 and	 CSA	 (10	 mg,	 0.04	 mmol,	 0.15	 equiv).	 The	 resulting	 mixture	 was	
refluxed	for	24	h.	A	saturated	aqueous	solution	of	NaHCO3	(5	mL)	was	added	and	the	aqueous	
layer	was	extracted	with	CH2Cl2	(3x5	mL),	and	the	combined	organic	extracts	were	washed	with	
brine	 (15	 mL),	 dried	 over	 anhydrous	 MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	
mixture	was	then	purified	by	flash	chromatography	(petroleum	ether/Et2O:	95/5)	to	afford	the	
protected	alcohol	18d	(80	mg,	0.16	mmol,	61%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	
ppm:	7.23	(d,	J	=	8.6	Hz,	2H),	6.86	(d,	J	=	8.6	Hz,	2H),	5.80-5.68	(m,	2H),	5.35-5.30	(m,	2H),	5.06-
4.98	(m,	2H),	4.54	(d,	J	=	11.2	Hz,	1H),	4.32	(d,	J	=	11.2	Hz,	1H),	3.81	(s,	3H),	3.47	(dd,	J	=	7.4,	2.2	
Hz,	1H),	2.82	(dd,	J	=	16.3,	5.5	Hz,	1H),	2.63	(dd,	J	=	16.3,	7.6	Hz,	1H),	2.53	(dd,	J	=	14.4,	7.4	Hz,	
1H),	2.32-2.19	(m,	2H),	2.10	(dq,	J	=	18.3,		5.9	Hz,	1H),	1.91-1.82	(m,	1H),	1.81-1.73	(m,	1H),	1.77	
(s,	3H),	1.70	 (s,	3H),	1.55	 (s,	3H),	1.29	 (s,	6H),	1.22	 (s,	3H).	 13C	NMR	 (126	MHz,	CDCl3)	δ	ppm:	
158.9,	155.0,	138.9,	134.5,	132.2,	131.2,	130.8,	128.8,	119.3,	117.4,	113.6,	89.9,	83.0,	82.2,	79.5,	
79.0,	70.5,	55.3,	43.6,	42.5,	42.0,	31.1,	25.8,	24.8,	24.5,	22.7,	20.8,	20.7,	18.0,	3.5.	IR	(ν,	cm-1):	
3054,	2978,	2936,	1794,	1666,	1605,	1520,	1438,	1280,	1172,	1025.	HRMS	(EI)	m/z:	[M]+	Calcd	
for	C32H42O5	506.3032,	found	506.3029.	[α]
21
D
:	-3.0	(c	1.5,	CHCl3).	
(4S,5S)-5-((5S,6S)-6-Allyl-5-(methoxymethoxy)-6-methylcyclohex-1-en-1-yl)-4-(3-methylbut-2-
en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	 (18e).	To	 a	 solution	of	 alcohol	18a	 (40	
mg,	0.10	mmol)	in	CH2Cl2	(3	mL)	were	added	DIPEA	(0.12	mL,	0.70	mmol,	7.0	equiv),	TBAI	(7	mg,	
0.02	mmol,	0.2	equiv)	and	MOMCl	 (35	µL,	92%	solution,	0.40	mmol,	4.0	equiv).	The	 resulting	
mixture	 was	 allowed	 to	 stir	 at	 room	 temperature	 for	 16	 h.	 A	 saturated	 aqueous	 solution	 of	
NaHCO3	(5	mL)	was	added	and	the	aqueous	layer	was	extracted	with	CH2Cl2	(3x5	mL),	and	the	
combined	organic	extracts	were	washed	with	a	saturated	aqueous	solution	of	CuSO4	(2x10	mL).	
The	aqueous	cuptrate	solution	was	extracted	with	CH2Cl2	(3x20	mL)	and	the	combined	organic	
extracts	 were	 washed	 with	 brine	 (2x100	 mL),	 dried	 over	 anhydrous	 MgSO4,	 filtered	 and	
concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	 chromatography	
(petroleum	ether/Et2O:	85/15)	to	afford	the	protected	alcohol	18g	(37	mg,	0.09	mmol,	86%)	as	a	
colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.82-5.70	(m,	2H),	5.36-5.30	(m,	2H),	5.10-5.02	
(m,	2H),	4.69	(d,	J	=	6.9	Hz,	1H),	4.61	(d,	J	=	6.9	Hz,	1H),	3.65	(dd,	J	=	6.8,	2.3	Hz,	1H),	3.38	(s,	3H),	
2.81	(dd,	J	=	16.5,	5.9	Hz,	1H),	2.63	(dd,	J	=	16.5,	7.2	Hz,	1H),	2.48	(dd,	J	=	14.4,	7.0	Hz,	1H),	2.32-
2.18	(m,	2H),	2.13	(ddt,	J	=	18.7,	6.0,	5.1	Hz,	1H),	1.90-1.74	(m,	2H),	1.78	(s,	3H),	1.70	(d,	J	=	1.1	
Hz,	3H),	1.60	(s,	3H),	1.30	(s,	6H),	1.23	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.0,	138.4,	
134.0,	132.3,	131.0,	119.1,	117.9,	95.9,	89.8,	83.0,	81.9,	79.5,	78.0,	55.7,	43.6,	42.0,	41.9,	31.0,	
25.8,	 24.8,	 24.5,	 22.5,	 22.1,	 20.8,	 18.1,	 3.6.	 IR	 (ν,	 cm-1):	 3055,	 2986,	 2306,	 1792,	 1541,	 1507,	
1421,	1260,	1038.	HRMS	(CI/ISO)	m/z:	[M+H]+	Calcd	for	C26H39O5	431.2797,	found	431.2794.	
[α]
27
D
:	-12.0	(c	1.0,	CHCl3).	
(4S,5S)-5-((5S,6S)-6-Allyl-5-((benzyloxy)methoxy)-6-methylcyclohex-1-en-1-yl)-4-(3-methylbut-
2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	(18f).	To	a	solution	of	alcohol	18a	(1.4	
g,	3.7	mmol)	in	CH2Cl2	(50	mL)	were	added	DIPEA	(4.8	mL,	28	mmol,	7.5	equiv),	TBAI	(1.6	g,	4.3	
mmol,	1.1	equiv)	and	BOMCl	(3.5	mL,	75%	solution,	19	mmol,	5.0	equiv).	The	resulting	mixture	
was	 allowed	 to	 reflux	 for	 16	 h.	 After	 the	 reaction	 mixture	 was	 cooled	 down	 to	 room	
temperature	an	aqueous	solution	of	1N	NaOH	(25	mL)	was	added	and	stirred	for	5-10	min.	The	
aqueous	 layer	 was	 extracted	 with	 Et2O	 (3x50	 mL),	 and	 the	 combined	 organic	 extracts	 were	
washed	with	a	saturated	aqueous	solution	of	CuSO4	(2x50	mL)	The	aqueous	copper	solution	was	
extracted	 with	 Et2O	 (3x100	mL)	 and	 the	 combined	 organic	 extracts	 were	 washed	 with	 brine	
(2x350	mL),	dried	over	anhydrous	MgSO4,	filtered	and	concentrated	in	vacuo.	The	crude	mixture	
was	 then	purified	by	 flash	chromatography	 (petroleum	ether/Et2O:	95/5	 to	9/1)	 to	afford	 the	
protected	 alcohol	18f	 (1.7	 g,	 3.4	mmol,	 95%)	 as	 a	 colourless	oil.	 1H	NMR	 (500	MHz,	CDCl3)	 δ	
ppm:	7.38-7.29	(m,	5H),	5.81	(t,	J	=	3.8	Hz,	1H),	5.79-5.71	(m,	1H),	5.38-5.32	(m,	2H),	5.10-5.02	
(m,	2H),	4.83	(d,	J	=	7.1	Hz,	1H),	4.75	(d,	J	=	7.1	Hz,	1H),	4.62	(s,	2H),	3.74	(dd,	J	=	6.5,	2.4	Hz,	1H),	
2.87-2.79	(m,	1H),	2.64	(dd,	J	=	16.4,	7.3	Hz,	1H),	2.50	(dd,	J	=	14.5,	6.9	Hz,	1H),	2.33-2.19	(m,	
2H),	2.18-2.09	(m,	1H),	1.94-1.81	(m,	2H),	1.78	(s,	3H),	1.70	(d,	J	=	1.0	Hz,	3H),	1.60	(s,	3H),	1.30	
(s,	6H),	1.26	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.0,	138.3,	137.9,	134.0,	132.3,	130.9,	
128.4,	127.8,	127.7,	119.2,	118.0,	93.9,	89.8,	83.0,	82.0,	79.5),	78.2,	69.7,	43.8,	42.0,	41.8,	31.0,	
25.8,	 24.8,	 24.5,	 22.4,	 21.9,	 20.8,	 18.1,	 3.6.	 IR	 (ν,	 cm-1):	 3054,	 2986,	 2306,	 1792,	 1558,	 1421,	
1265,	 1041,	 1033.	HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C32H42O5Na	 529.2924,	 found	
529.2916.	[α]
25
D
:	-10.0	(c	1.0,	CHCl3).	
(4S,5S)-5-((5S,6S)-6-Allyl-5-methoxy-6-methylcyclohex-1-en-1-yl)-4-(3-methylbut-2-en-1-yl)-4-
(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one	 (18g).	 To	 a	 solution	 of	 alcohol	 18a	 (40	 mg,	 0.1	
mmol)	 in	DMF	 (1.5	mL)	were	 added	at	 0	 °C	NaH	 (6.0	mg,	 60%	 in	mineral	 oil,	 0.15	mmol,	 1.5	
equiv)	and	MeI	(12	µL,	0.20	mmol,	2.0	equiv).	The	resulting	mixture	was	allowed	to	stir	for	16	h	
at	 room	 temperature.	 A	 saturated	 aqueous	 solution	 of	 NaHCO3	 (5	 mL)	 was	 added	 and	 the	
aqueous	 layer	 was	 extracted	 with	 Et2O	 (3x5	 mL),	 then	 the	 combined	 organic	 extracts	 were	
washed	with	brine	 (15	mL),	dried	over	anhydrous	MgSO4,	 filtered	and	concentrated	 in	 vacuo.	
The	crude	mixture	was	purified	by	flash	chromatography	(petroleum	ether/Et2O:	95/5)	to	afford	
the	protected	alcohol	18g	(35	mg,	0.09	mmol,	87%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	
δ	ppm:	5.82-5.68	(m,	2H),	5.35-5.27	(m,	2H),	5.10-4.99	(m,	2H),	3.30	(s,	3H),	3.22	(dd,	J	=	8.0,	2.5	
Hz,	1H),	2.81	(dd,	J	=	16.3,	6.0	Hz,	1H),	2.64	(dd,	J	=	16.3,	7.0	Hz,	1H),	2.49	(dd,	J	=	14.4,	7.5	Hz,	
1H),	2.29-2.16	(m,	2H),	2.13-2.03	(m,	1H),	1.83	(dtd,	J	=	13.4,	6.5,	2.7	Hz,	1H),	1.76	(s,	3H),	1.73-
1.67	(m,	1H),	1.70	(d,	J	=	1.2	Hz,	3H),	1.59	(s,	3H),	1.29	(s,	6H),	1.17	(s,	3H).	13C	NMR	(126	MHz,	
CDCl3)	δ	ppm:	155.0,	138.9,	134.6,	132.3,	131.0,	119.1,	117.4,	89.7,	83.0,	81.6,	80.7,	79.6,	56.5,	
43.2,	42.4,	41.9,	31.0,	25.8,	24.8,	24.5,	22.7,	20.5,	20.0,	18.0,	3.5.	IR	(ν,	cm-1):	3074,	2977,	2920,	
2208,	 1801,	 1637,	 1458,	 1363,	 1170,	 1090.	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	
C25H36O4Na	423.2506,	found	423.2488.	[α]
22
D
:	-28.0	(c	2.0,	CHCl3).	
(3S,7S,8S,11S,Z)-8-Hydroxy-7-methyl-3-(2-methylpent-3-yn-2-yl)-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	(20a).	A	solution	of	alcohol	18a	(35	mg,	90	
µmol)	 in	 toluene	 (30	mL)	was	 thoroughly	degassed	under	argon	 (using	 the	 freeze-thaw	pump	
technique)	and	Zhan-1B	catalyst	(7.0	mg,	9.0	µmol,	0.1	equiv)	was	added	and	the	mixture	was	
stirred	at	reflux	for	16	h.	The	resulting	mixture	was	allowed	to	cool	down	and	the	solvent	was	
removed	 in	 vacuo.	 The	 crude	mixture	was	 then	purified	by	 flash	 chromatography	 (petroleum	
ether/EtOAc:	 85/15)	 to	 afford	 the	 title	 bicycle	 compound	 20a	 (9.5	 mg,	 29	 µmol,	 23%)	 as	 a	
colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.90	(t,	J	=	3.7	Hz,	1H),	5.87-5.79	(m,	1H),	5.69	
(td,	J	=	9.0,	7.0	Hz,	1H),	5.28	(s,	1H),	3.57	(br	s,	1H),	2.62-2.51	(m,	2H),	2.44-2.31	(m,	2H),	2.28	
(dd,	J	=	13.5,	7.0	Hz,	1H),	2.10-2.02	(m,	1H),	1.87	(dd,	J	=	13.5,	9.0	Hz,	1H),	1.84-1.78	(m,	1H),	
1.75	(s,	3H),	1.61	(br	s,	1H),	1.40	(s,	3H),	1.34	(s,	3H),	1.21	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	
ppm:	154.9,	136.9,	128.7,	127.1,	126.8,	91.0,	83.1,	81.0,	80.6,	76.0,	44.5,	39.5,	39.1,	32.0,	25.6,	
24.9,	23.7,	20.5,	18.7,	3.7.	IR	(ν,	cm-1):	3300,	3032,	2923,	2854,	2254,	1798,	1643,	1466,	1272,	
1172,	1040.	HRMS	(CI/ISO)	m/z:	[M+H]+	Calcd	for	C20H27O4	331.1909,	found	331.1912.	[α]
25
D
:	
+143	(c	1.0,	CHCl3).	
(3S,7S,8S,11S,Z)-7-Methyl-3-(2-methylpent-3-yn-2-yl)-8-((triethylsilyl)oxy)-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20b).	 The	 same	 metathesis	 procedure	
was	repeated	with	the	protected	alcohol	18b	(35	mg,	70	µmol).	The	crude	mixture	was	purified	
by	 flash	 chromatography	 (petroleum	ether/EtOAc:	 97/3)	 to	 afford	 the	 title	 bicycle	 compound	
20b	(24	mg,	54	µmol,	77%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.83-5.74	(m,	
2H),	5.69-5.61	(m,	1H),	5.27	(s,	1H),	3.60	(dd,	J	=	4.6,	2.0	Hz,	1H),	2.61	(ddd,	J	=	14.0,	9.6,	0.9	Hz,	
1H),	2.52	(dd,	J	=	14.0,	7.3	Hz,	1H),	2.40-2.30	(m,	1H),	2.27	(dd,	J	=	13.6,	6.5	Hz,	1H),	2.20-2.10	
(m,	1H),	1.99-1.91	(m,	1H),	1.84	(dd,	J	=	13.6,	8.5	Hz,	1H),	1.75	(s,	3H),	1.65	(dddd,	J	=	14.0,	7.3,	
4.8,	2.0	Hz,	1H),	1.39	(s,	3H),	1.34	(s,	3H),	1.10	(s,	3H),	0.96	(t,	J	=	8.0	Hz,	9H),	0.60	(q,	J	=	8.0	Hz,	
6H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.1,	136.4,	128.9,	126.9,	126.2,	91.2,	83.2,	80.7,	80.6,	
76.3,	44.4,	39.3,	39.2,	32.1,	25.6,	24.9,	24.8,	21.7,	19.3,	7.0,	5.1,	3.7.	 IR	 (ν,	 cm-1):	3055,	2955,	
2877,	 1796,	 1466,	 1427,	 1265,	 1187,	 1056.	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	
C26H40O4SiNa	467.2588,	found	467.2568.	[α]
22
D
:	+133	(c	2.0,	CHCl3).	
(3S,7S,8S,11S,Z)-7-Methyl-3-(2-methylpent-3-yn-2-yl)-2-oxo-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-8-yl	 acetate	 (20c).	 The	 same	 metathesis	
procedure	was	 repeated	with	 the	protected	alcohol	18c	 (36	mg,	84	µmol).	The	crude	mixture	
was	purified	by	flash	chromatography	(petroleum	ether/Et2O:	85/15)	to	afford	the	title	bicycle	
20c	(25	mg,	67	µmol,	80%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.90-5.81	(m,	
2H),	5.70-5.63	(m,	1H),	5.31	(s,	1H),	4.88	(dd,	J	=	3.8,	2.4	Hz,	1H),	2.64-2.52	(m,	2H),	2.36-2.25	
(m,	3H),	2.05	(s,	3H),	2.04-1.99	(m,	1H),	1.96	(dd,	J	=	13.5,	8.7	Hz,	1H),	1.91-1.84	(m,	1H),	1.73	(s,	
3H),	 1.40	 (s,	 3H),	 1.35	 (s,	 3H),	 1.10	 (s,	 3H).b13C	NMR	 (126	MHz,	CDCl3)	 δ	 ppm:	 170.9,	 154.9,	
136.3,	128.1,	127.5,	126.7,	91.1,	83.2,	80.9,	80.6,	77.6,	42.7,	39.4,	39.1,	32.0,	25.6,	24.9,	21.4,	
21.3,	21.2,	18.5,	3.6.	IR	(ν,	cm-1):	3055,	3034,	2984,	2920,	1796,	1726,	1466,	1373,	1249,	1164,	
1033.	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C22H28O5Na	 395.1829,	 found	 395.1815.	
[α]
26
D
:	+126	(c	2.0,	CHCl3).	
(3S,9S,10S,13S,Z)-10-((4-Methoxybenzyl)oxy)-6,9,14,14-tetramethyl-9,9,10,11,12,13-
hexahydro-4H-3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19d)	 and	
(3S,7S,8S,11S,Z)-8-((4-methoxybenzyl)oxy)-7-methyl-3-(2-methylpent-3-yn-2-yl)-
3,4,7,7,8,9,10,11-octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20d).	 The	 same	
metathesis	procedure	was	repeated	with	the	protected	diol	18d	(50	mg,	0.10	mmol).	The	crude	
mixture	was	purified	by	flash	chromatography	(petroleum	ether/Et2O:	85/15)	to	afford	the	title	
tricycle	19d	(13	mg,	29	µmol,	29%)	and	the	bicycle	20d	(9.9	mg,	22	µmol,	22%)	as	colourless	oils.	
(3S,9S,10S,13S,Z)-10-((4-Methoxybenzyl)oxy)-6,9,14,14-tetramethyl-9,9,10,11,12,13-
hexahydro-4H-3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19d).	 1H	 NMR	 (400	
MHz,	CDCl3)	δ	ppm:	7.33-7.28	(m,	2H),	6.93-6.89	(m,	2H),	5.87	(dd,	J	=	5.7,	1.7	Hz,	1H),	5.10	(s,	
1H),	5.03	(dd,	J	=	13.0,	6.1	Hz,	1H),	4.88	(tq,	J	=	3.3,	1.6	Hz,	1H),	4.70	(d,	J	=	11.9	Hz,	1H),	4.38	(d,	
J	=	11.9	Hz,	1H),	3.81	(s,	3H),	3.30	(dd,	J	=	12.1,	3.3	Hz,	1H),	2.74	(ddq,	J	=	18.8,	3.3,	1.6	Hz,	1H),	
2.61	(dd,	J	=	13.8,	6.1	Hz,	1H),	2.26	(dd,	J	=	13.8,	13.0	Hz,	1H),	2.25-2.19	(m,	1H),	2.14	(ddq,	J	=	
18.8,	3.3,	1.6	Hz,	1H),	2.05-1.97	(m,	2H),	1.62	(q,	J	=	1.6	Hz,	3H),	1.66-1.60	(m,	1H),	1.53	(s,	3H),	
1.28	(s,	3H),	1.14	(s,	3H).	13C	NMR	 (126	MHz,	CDCl3)	δ	ppm:	159.3,	154.2,	146.1,	138.1,	134.9,	
130.5,	129.9,	127.9,	127.4,	115.6,	113.8,	93.3,	78.9,	74.9,	69.8,	55.3,	47.7,	41.0,	32.6,	30.6,	25.1,	
24.2,	21.7,	21.5,	21.2,	18.5.	IR	(ν,	cm-1):	3054,	2980,	2934,	1797,	1620,	1458,	1420,	1242,	1025.	
HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C28H34O5Na	473.2298,	found	473.2278.	[α]
21
D
:	+120	
(c	1.0,	 CHCl3).	 (3S,7S,8S,11S,Z)-8-((4-methoxybenzyl)oxy)-7-methyl-3-(2-methylpent-3-yn-2-yl)-
3,4,7,7,8,9,10,11-octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20d).	 1H	 NMR	 (500	
MHz,	CDCl3)	δ	ppm:	7.25	(d,	J	=	8.7	Hz,	2H),	6.88	(d,	J	=	8.7	Hz,	2H),	5.84-5.75	(m,	2H),	5.64-5.56	
(m,	1H),	5.31	(s,	1H),	4.59	(d,	J	=	11.8	Hz,	1H),	4.37	(d,	J	=	11.8	Hz,	1H),	3.82	(s,	3H),	3.28	(dd,	J	=	
4.2,	2.2	Hz,	1H),	2.60	(dd,	J	=	13.7,	10.9	Hz,	1H),	2.53	(dd,	J	=	13.7,	7.3	Hz,	1H),	2.35-2.27	(m,	2H),	
2.20	(ddt,	J	=	19.1,	6.3,	3.1	Hz,	1H),	1.93-1.82	(m,	3H),	1.73	(s,	3H),	1.39	(s,	3H),	1.33	(s,	3H),	1.15	
(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	159.0,	155.0,	136.9,	131.1,	129.1,	128.8,	126.9,	126.6,	
113.7,	91.1,	83.2,	82.0,	80.6,	77.2,	70.3,	55.3,	43.8,	39.5,	39.2,	32.1,	25.6,	24.9,	21.7,	19.7,	19.2,	
3.7.	 IR	 (ν,	 cm-1):	 3042,	 2980,	 2943,	 2832,	 1800,	 1612,	 1497,	 1458,	 1257,	 1187,	 1041.	HRMS	
(ESI/TOF-Q)	m/z:	 [M+Na]+	 Calcd	 for	 C28H34O5Na	 473.2298,	 found	 473.2277.	 [α]
21
D
:	 +90.0	 (c	
1.0,	CHCl3).	
(3S,9S,10S,13S,Z)-10-(Methoxymethoxy)-6,9,14,14-tetramethyl-9,9,10,11,12,13-hexahydro-4H-
3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19e)	 and	 (3S,7S,8S,11S,Z)-8-
(Methoxymethoxy)-7-methyl-3-(2-methylpent-3-yn-2-yl)-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20e).	 The	 same	 metathesis	 procedure	
was	repeated	with	the	protected	alcohol	18e	(33	mg,	76	µmol).	The	crude	mixture	was	purified	
by	 flash	 chromatography	 (petroleum	ether/Et2O:	 85/15)	 to	 afford	 the	 title	 tricycle	 compound	
19e	 (8.0	 mg,	 21	 µmol,	 28%)	 and	 the	 bicycle	 20e	 (15	 mg,	 41	 µmol,	 54%)	 as	 colourless	 oils.	
(3S,9S,10S,13S,Z)-10-(Methoxymethoxy)-6,9,14,14-tetramethyl-9,9,10,11,12,13-hexahydro-4H-
3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	(19e).	1H	NMR	(400	MHz,	CDCl3)	δ	ppm:	
5.91	(dd,	J	=	5.2,	2.0	Hz,	1H),	5.70	(dd,	J	=	12.9,	6.1	Hz,	1H),	5.15	(s,	1H),	4.95	(tq,	J	=	3.3,	1.6	Hz,	
1H),	4.82	(d,	J	=	7.0	Hz,	1H),	4.65	(d,	J	=	7.0	Hz,	1H),	3.62	(dd,	J	=	12.1,	3.9	Hz,	1H),	3.45	(s,	3H),	
2.79	(ddq,	J	=	18.9,	3.3,	1.6	Hz,	1H),	2.65	(dd,	J	=	13.8,	6.1	Hz,	1H),	2.40	(dd,	J	=	13.8,	12.9	Hz,	
1H),	2.26-2.13	(m,	2H),	2.04	(dddd,	J	=	18.5,	11.6,	6.6,	2.0	Hz,	1H),	1.93-1.85	(m,	1H),	1.79	(q,	J	=	
1.6	Hz,	3H),	1.75-1.65	(m,	1H),	1.59	(s,	3H),	1.34	(s,	3H),	1.15	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	
ppm:	 154.1,	 146.7,	 138.2,	 134.6,	 128.1,	 127.0,	 115.8,	 95.3,	 93.4,	 79.0,	 75.7,	 55.8,	 47.5,	 41.1,	
32.8,	30.6,	25.2,	24.2,	23.1,	21.7,	21.3,	18.9.	 IR	 (ν,	cm-1):	3049,	2932,	1799,	1558,	1435,	1266,	
1020.	HRMS	(CI/ISO)	m/z:	[M+H]+	Calcd	for	C22H31O5	375.2171,	found	375.2175.	[α]
24
D
:	+84.0	
(c	 1.0,	 CHCl3).	 (3S,7S,8S,11S,Z)-8-(Methoxymethoxy)-7-methyl-3-(2-methylpent-3-yn-2-yl)-
3,4,7,7,8,9,10,11-octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20e).	 1H	 NMR	 (500	
MHz,	CDCl3)	δ	ppm:	5.87-5.79	(m,	2H),	5.71-5.60	(m,	1H),	5.31	(s,	1H),	4.74	(d,	J	=	7.0	Hz,	1H),	
4.62	(d,	J	=	7.0	Hz,	1H),	3.52	(dd,	J	=	4.0,	2.4	Hz,	1H),	3.40	(s,	3H),	2.64-2.50	(m,	2H),	2.35-2.28	
(m,	2H),	2.27-2.22	(m,	1H),	1.97-1.86	(m,	3H),	1.75	(s,	3H),	1.40	(s,	3H),	1.34	(s,	3H),	1.20	(s,	3H).	
13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.0,	136.8,	128.6,	127.1,	126.7,	95.4,	91.0,	83.2,	81.3,	80.7,	
80.6,	55.8,	43.6,	39.7,	39.1,	32.1,	25.6,	24.9,	21.7,	21.0,	19.1,	3.7.	IR	(ν,	cm-1):	3056,	3034,	2987,	
2941,	1798,	1527,	1450,	1257,	1041.	HRMS	(CI/ISO)	m/z:	[M+H]+	Calcd	for	C22H31O5	375.2171,	
found	375.2168.	[α]
25
D
:	+157	(c	1.0,	CHCl3).	
(3S,9S,10S,13S,Z)-10-((Benzyloxy)methoxy)-6,9,14,14-tetramethyl-9,9,10,11,12,13-hexahydro-
4H-3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19f)	 (3S,7S,8S,11S,Z)-8-
((Benzyloxy)methoxy)-7-methyl-3-(2-methylpent-3-yn-2-yl)-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20f).	 Method	 A:	 The	 same	 metathesis	
procedure	was	 repeated	with	 the	protected	alcohol	 18f	 (20	mg,	39	µmol).	The	crude	mixture	
was	 purified	 by	 flash	 chromatography	 (benzene/CH2Cl2:	 75/25)	 to	 afford	 the	 title	 tricycle	19f	
(5.3	mg,	12	µmol,	29%)	and	the	bicycle	20f	(7.9	mg,	18	µmol,	46%)	as	colourless	oils.	Method	B:	
A	solution	of	18f	(100	mg,	0.20	mmol)	in	toluene	(65	mL)	was	thoroughly	degassed	under	argon	
(using	the	freeze-thaw	pump	technique)	and	Zhan-1B	catalyst	 (144	mg,	0.20	mmol,	1.0	equiv)	
was	added	and	 the	mixture	was	stirred	at	 reflux	 for	16	h	while	a	gentle	 stream	of	argon	was	
bubbling	through	the	reaction	mixture.	The	resulting	mixture	was	allowed	to	cool	down	and	the	
solvent	was	 removed	 in	vacuo.	The	crude	mixture	was	 then	purified	by	 flash	chromatography	
(benzene/CH2Cl2:	75/25)	to	only	afford	the	title	tricycle	compound	19f	(32-36	mg,	70-80	µmol,	
35-40%)	as	a	colourless	oil.	Method	C:	A	solution	of	precursor	18f	(36	mg,	71	µmol)	in	toluene	
(24	mL)	 was	 thoroughly	 degassed	 under	 argon	 (using	 the	 freeze-thaw	 pump	 technique)	 and	
Zhan-1B	catalyst	(52	mg,	71	µmol,	1.0	equiv)	was	added	and	the	mixture	was	stirred	at	reflux	for	
4	h	while	a	gentle	stream	of	argon	was	bubbling	through	the	reaction	mixture.	Then	a	solution	
of	bicycle	20f	(32	mg,	71	µmol,	1.0	equiv)	in	toluene	(5	mL)	was	added	to	the	reaction	mixture,	
which	was	stirred	at	reflux	for	an	additional	16	h	while	a	gentle	stream	of	argon	was	bubbling	
through.	 The	 resulting	 mixture	 was	 allowed	 to	 cool	 down	 and	 the	 solvent	 was	 removed	 in	
vacuo.	The	crude	mixture	was	then	purified	by	flash	chromatography	(benzene/CH2Cl2:	75/25)	
to	 afford	 the	 title	 tricycle	 compound	 19f	 (15	 mg,	 33	 µmol,	 47%)	 as	 a	 colourless	 oil.	
(3S,9S,10S,13S,Z)-10-((Benzyloxy)methoxy)-6,9,14,14-tetramethyl-9,9,10,11,12,13-hexahydro-
4H-3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19f).	 1H	 NMR	 (500	MHz,	CDCl3)	 δ	
ppm:	7.38-7.29	(m,	5H),	5.91	(dd,	J	=	5.6,	2.1	Hz,	1H),	5.68	(dd,	J	=	13.2,	6.1	Hz,	1H),	5.16	(s,	1H),	
4.96	(d,	J	=	7.2	Hz,	1H),	4.93	(ddq,	J	=	6.2,	3.6,	1.6	Hz,	1H),	4.82	(d,	J	=	7.2	Hz,	1H),	4.74	(d,	J	=	
11.6	Hz,	1H),	4.65	(d,	J	=	11.6	Hz,	1H),	3.72	(dd,	J	=	12.1,	3.8	Hz,	1H),	2.78	(ddq,	J	=	19.0,	3.6,	1.6	
Hz,	1H),	2.71	(dd,	J	=	13.2,	6.1	Hz,	1H),	2.42	(t,	J	=	13.2	Hz,	1H),	2.26-2.14	(m,	2H),	2.04	(dddd,	J	=	
18.4,	11.7,	6.7,	2.1	Hz,	1H),	1.98-1.91	(m,	1H),	1.74-1.65	(m,	1H),	1.71	(dt,	J	=	3.3,	1.6	Hz,	3H),	
1.59	 (s,	3H),	1.33	 (s,	3H),	1.17	 (s,	3H).	 13C	NMR	 (126	MHz,	CDCl3)	δ	ppm:	154.1,	146.7,	138.3,	
137.6,	134.6,	128.5,	128.1,	127.8,	127.7,	127.0,	115.8,	93.4,	93.2,	78.9,	75.5,	70.1,	47.5,	41.1,	
32.8,	30.6,	25.2,	24.1,	22.9,	21.7,	21.3,	18.8.	 IR	 (ν,	cm-1):	3056,	3030,	2934,	1801,	1541,	1377,	
1338,	 1267,	 1216,	 1159,	 1025.	 	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C28H34O5Na	
473.2298,	found	473.2287.	[α]
21
D
:	+113	(c	1.0,	CHCl3).	(3S,7S,8S,11S,Z)-8-((Benzyloxy)methoxy)-
7-methyl-3-(2-methylpent-3-yn-2-yl)-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20f).	 1H	 NMR	 (500	 MHz,	 CDCl3)	 δ	 ppm:	
7.39-7.29	(m,	5H),	5.89-5.78	(m,	2H),	5.71-5.63	(m,	1H),	5.33	(s,	1H),	4.88	(d,	J	=	7.2	Hz,	1H),	4.78	
(d,	J	=	7.2	Hz,	1H),	4.67	(d,	J	=	11.5	Hz,	1H),	4.63	(d,	J	=	11.5	Hz,	1H),	3.62	(t,	J	=	3.1	Hz,	1H),	2.61	
(dd,	J	=	13.5,	10.3	Hz,	1H),	2.55	(dd,	J	=	13.5,	7.3	Hz,	1H),	2.41-2.29	(m,	2H),	2.28-2.20	(m,	1H),	
2.00-1.86	(m,	3H),	1.75	(s,	3H),	1.41	(s,	3H),	1.35	(s,	3H),	1.22	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	
δ	ppm:	155.0,	137.9,	136.8,	128.6,	128.5,	127.8,	127.7,	127.2,	126.7,	93.5,	91.0,	83.2,	81.5,	80.7,	
80.6,	69.9,	43.7,	39.7,	39.2,	32.1,	25.6,	24.9,	21.7,	20.9,	19.1,	3.7.	IR	(ν,	cm-1):	3056,	3014,	2989,	
2951,	 1791,	 1520,	 1423,	 1400,	 1257,	 1125,	 1041.	HRMS	 (ESI/TOF-Q)	m/z:	 [M+Na]+	 Calcd	 for	
C28H34O5Na	473.2298,	found	473.2287.	[α]
25
D
:	+123	(c	1.0,	CHCl3).	
(3S,9S,10S,13S,Z)-10-Methoxy-6,9,14,14-tetramethyl-9,9,10,11,12,13-hexahydro-4H-3,7-
methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19g)	 and	 (3S,7S,8S,11S,Z)-8-methoxy-7-
methyl-3-(2-methylpent-3-yn-2-yl)-3,4,7,7,8,9,10,11-
octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	 (20g).	 The	 same	 metathesis	 procedure	
was	repeated	with	the	protected	alcohol	18g	(34	mg,	85	µmol).	The	crude	mixture	was	purified	
by	flash	chromatography	(petroleum	ether/Et2O:	85/15)	to	afford	the	title	tricycle	19g	(13	mg,	
38	µmol,	45%)	and	the	bicycle	20g	(8.8	mg,	25	µmol,	30%)	as	colourless	oils.	(3S,9S,10S,13S,Z)-
10-Methoxy-6,9,14,14-tetramethyl-9,9,10,11,12,13-hexahydro-4H-3,7-
methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	 (19g).	 1H	 NMR	 (500	 MHz,	 CDCl3)	 δ	 ppm:	
5.90	(dd,	J	=	5.0,	1.5	Hz,	1H),	5.65	(dd,	J	=	13.7,	6.2	Hz,	1H),	5.13	(s,	1H),	4.95	(tq,	J	=	3.5,	1.8	Hz,	
1H),	3.43	(s,	3H),	3.18	(dd,	J	=	12.1,	3.4	Hz,	1H),	2.79	(ddq,	J	=	18.9,	3.5,	1.8	Hz,	1H),	2.68	(dd,	J	=	
13.7,	6.2	Hz,	1H),	2.36	(t,	J	=	13.7	Hz,	1H),	2.28-2.15	(m,	2H),	2.06-1.94	(m,	2H),	1.80	(q,	J	=	1.8	
Hz,	3H),	1.58	(s,	3H),	1.57-1.52	(m,	1H),	1.33	(s,	3H),	1.10	(s,	3H).	13C	NMR	 (126	MHz,	CDCl3)	δ	
ppm:	 154.2,	 146.5,	 138.2,	 134.7,	 127.9,	 127.3,	 115.9,	 93.3,	 79.5,	 79.0,	 57.2,	 47.8,	 41.1,	 32.8,	
30.6,	25.2,	24.2,	21.6,	21.3,	21.3,	18.8.	IR	(ν,	cm-1):	3054,	2983,	2931,	1797,	1507,	1434,	1265,	
1211,	 1172,	 1110,	 1025.	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C21H28O4Na	 367.1880,	
found	 367.1863.	 [α]
25
D
:	 +105	 (c	 1.5,	 CHCl3).	 (3S,7S,8S,11S,Z)-8-methoxy-7-methyl-3-(2-
methylpent-3-yn-2-yl)-3,4,7,7,8,9,10,11-octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	
(20g).	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	5.83-5.77	(m,	2H),	5.70-5.61	(m,	1H),	5.30	(s,	1H),	3.36	
(s,	3H),	3.08	(dd,	J	=	4.4,	2.2	Hz,	1H),	2.59	(ddd,	J	=	13.6,	9.7,	1.0	Hz,	1H),	2.54	(dd,	J	=	13.6,	7.3	
Hz,	1H),	2.35-2.25	(m,	2H),	2.23-2.15	(m,	1H),	1.95	(ddt,	J	=	14.2,	6.5,	2.2	Hz,	1H),	1.91-1.84	(m,	
2H),	1.74	(s,	3H),	1.39	(s,	3H),	1.33	(s,	3H),	1.17	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	155.0,	
136.9,	128.7,	127.1,	126.6,	91.0,	85.2,	83.2,	80.7,	80.6,	57.0,	43.8,	39.6,	39.2,	32.1,	25.6,	24.9,	
21.5,	19.1,	18.9,	3.7.	IR	(ν,	cm-1):	3055,	2944,	2832,	1794,	1647,	1456,	1268,	1117,	1029.	HRMS	
(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C21H28O4Na	367.1880,	found	367.1862.	[α]
25
D
:	+175	(c	1.0,	
CHCl3).	
(4S,5S)-4-((5S,6S)-6-allyl-5-((benzyloxy)methoxy)-6-methylcyclohex-1-en-1-yl)-8,10,10-
trimethyl-9-methylene-1,3-dioxaspiro[4.5]dec-7-en-2-one	 (21f)	 and	 (3S,8S,9S,12S,Z)-3-Allyl-9-
((benzyloxy)methoxy)-4,4,6,8-tetramethyl-5-methylene-3,5,8,8,9,10,11,12-octahydro-4H-
benzo[3,4]cyclonona[1,2][1,3]dioxol-2-one	 (22f).	 Ethylene	 was	 bubbled	 for	 2	 min	 through	 a	
thoroughly	degassed	(using	the	freeze-thaw	pump	technique)	solution	of	precursor	18f	(20	mg,	
39	µmol)	 in	 toluene	 (13	mL)	 and	 Zhan-1B	 catalyst	 (3	mg,	 4	µmol,	 0.1	 equiv)	was	 added	 then	
ethylene	was	bubbled	 through	 the	 reaction	mixture	 for	 another	 2	min.	 The	 resulting	mixture	
was	refluxed	under	an	ethylene	atmosphere	for	2.5	h.	The	resulting	mixture	was	allowed	to	cool	
down	 and	 the	 solvent	 was	 removed	 in	 vacuo.	 The	 crude	mixture	 was	 then	 purified	 by	 flash	
chromatography	(petroleum	ether/Et2O:	85/15)	to	afford	the	title	bicycle	22f	(6.0	mg,	12	μmol,	
30%)	and	a	1:3.5	mixture	of	20f	/	21f	(13	mg,	27	μmol,	70%)	as	colourless	oils.	(3S,8S,9S,12S,Z)-
3-Allyl-9-((benzyloxy)methoxy)-4,4,6,8-tetramethyl-5-methylene-3,5,8,8,9,10,11,12-octahydro-
4H-benzo[3,4]cyclonona[1,2][1,3]dioxol-2-one	 (21f).	 1H	 NMR	 (400	MHz,	 CDCl3)	 δ	 ppm:	 7.40-
7.33	(m,	4H),	7.33-7.29	(m,	1H),	5.99	(t,	J	=	4.0	Hz,	1H),	5.73-5.59	(m,	2H),	5.16	(s,	1H),	5.10-5.02	
(m,	3H),	4.99	(s,	1H),	4.86	(d,	J	=	7.1	Hz,	1H),	4.77	(d,	J	=	7.1	Hz,	1H),	4.68-4.59	(m,	2H),	3.75	(dd,	
J	=	7.8,	2.6	Hz,	1H),	2.73-2.58	(m,	2H),	2.42-2.33	(m,	1H),	2.29-2.22	(m,	1H),	2.21-2.09	(m,	2H),	
1.98-1.87	(m,	1H),	1.91	(s,	3H),	1.85-1.76	(m,	1H),	1.32	(s,	3H),	1.24	(s,	3H),	1.23	(s,	3H).	13C	NMR	
(126	MHz,	CDCl3)	δ	ppm:	154.8,	149.8,	139.6,	138.2,	137.8,	133.5,	130.6,	128.4,	127.8,	127.7,	
123.0,	 118.3,	 113.1,	 98.3,	 94.0,	 77.6,	 76.4,	 69.8,	 52.9,	 42.9,	 42.2,	 38.9,	 23.3,	 23.1,	 22.7,	 22.3,	
21.1,	18.9.	IR	(ν,	cm-1):	3045,	2972,	2934,	1794,	1458,	1327,	1272,	1180,	1033.	HRMS	(ESI/TOF-
Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C30H38O5Na	 501.2611,	 found	 501.2602.	 (3S,7S,8S,11S,Z)-8-
((Benzyloxy)methoxy)-4,4,7-trimethyl-3-(3-methylbut-2-en-1-yl)-5-(prop-1-en-2-yl)-
3,4,7,7,8,9,10,11-octahydrobenzo[3,4]cycloocta[1,2][1,3]dioxol-2-one	(22f).	1H	NMR	(500	MHz,	
CDCl3)	δ	ppm:	7.36-7.29	(m,	5H),	6.07	(t,	J	=	3.6	Hz,	1H),	5.57	(dd,	J	=	10.7,	8.6	Hz,	1H),	5.38	(s,	
1H),	5.23	(tq,	J	=	7.2,	0.9	Hz,	1H),	4.95	(d,	J	=	7.1	Hz,	1H),	4.82	(d,	J	=	7.1	Hz,	1H),	4.80-4.76	(m,	
1H),	4.69	(d,	J	=	11.7	Hz,	1H),	4.65	(d,	J	=	11.7	Hz,	1H),	4.53	(d,	J	=	1.5	Hz,	1H),	3.71	(dd,	J	=	12.1,	
4.4	Hz,	1H),	2.61	(dd,	J	=	15.1,	7.2	Hz,	1H),	2.54-2.45	(m,	2H),	2.40-2.32	(m,	1H),	2.29	(m,	J	=	16.9,	
10.7	Hz,	1H),	2.24-2.19	(m,	1H),	2.08	(m,	1H),	1.88-1.79	(m,	1H),	1.77	(s,	3H),	1.72	(d,	J	=	0.9	Hz,	
3H”),	1.59	(s,	3H),	1.55	(s,	3H),	1.39	(s,	3H),	1.13	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	154.0,	
150.3,	 150.1,	 137.7,	 136.3,	 134.6,	 128.4,	 127.8,	 127.7,	 127.7,	 127.6,	 117.2,	 113.6,	 93.9,	 93.8,	
80.9,	76.2,	70.1,	43.8,	43.2,	33.6,	30.2,	26.2,	26.1,	26.0,	23.9,	23.7,	23.4,	23.1,	18.4.	IR	(ν,	cm-1):	
3056,	3025,	2998,	2921,	2284,	1799,	1686,	1521,	1436,	1265,	1025.	HRMS	(CI/ISO)	m/z:	[M+H]+	
Calcd	for	C32H43O5	507.3110,	found	507.3114.	[α]
25
D
:	+94.0	(c	1.0,	CHCl3).	
(1S,4S,7S,10R,11S,12S)-1-((Benzyloxy)methoxy)-10,12,13,13-tetramethyl-1,3,4,11,12,12-
hexahydro-2H,8H-7,10-methanobenzo[3,4]oxireno[2',3':6,7]cyclodeca[1,2][1,3]dioxol-6-one	
(23).	To	a	solution	of	triene	19f	(93	mg,	0.20	mmol)	in	CH2Cl2	(3	mL)	was	added	at	0	°C	a	solution	
of	mCPBA	(55	mg,	0.24	mmol,	1.2	equiv)	in	CH2Cl2	(1	mL).	The	resulting	mixture	was	stirred	at	
the	 same	 temperature	 for	 30	 min.	 The	 reaction	 mixture	 was	 washed	 with	 a	 10%	 aqueous	
solution	of	Na2SO3	 (2x4	mL),	and	the	aqueous	 layer	was	extracted	with	CH2Cl2	 (3x10	mL).	The	
combined	organic	extracts	were	washed	with	a	saturated	aqueous	solution	of	NaHCO3	(25	mL),	
washed	with	brine	 (25	mL),	 dried	over	MgSO4,	 filtered	and	 concentrated	 in	 vacuo.	 The	 crude	
mixture	was	 then	purified	by	 flash	chromatography	 (petroleum	ether/Et2O:	8/2)	 to	afford	 the	
title	vinyl	epoxide	23	(80	mg,	0.17	mmol,	86%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	
ppm:	7.38-7.29	(m,	5H),	6.10	(dd,	J	=	5.3,	1.5	Hz,	1H),	5.20	(tq,	J	=	3.4,	1.7	Hz,	1H),	5.10	(s,	1H),	
4.97	(d,	J	=	7.3	Hz,	1H),	4.82	(d,	J	=	7.3	Hz,	1H),	4.73	(d,	J	=	11.4	Hz,	1H),	4.64	(d,	J	=	11.4	Hz,	1H),	
3.86	(dd,	J	=	12.1,	3.7	Hz,	1H),	2.96	(ddq,	J	=	18.8,	3.4,	1.7	Hz,	1H),	2.72	(dd,	J	=	14.4,	4.0	Hz,	1H),	
2.63	(dd,	J	=	12.5,	4.0	Hz,	1H),	2.34	(ddq,	J	=	18.8,	3.4,	1.7	Hz,	1H),	2.30-2.24	(m,	1H),	2.11	(dddd,	
J	=	18.3,	11.7,	6.3,	1.5	Hz,	1H),	2.03-1.97	(m,	1H),	1.75	(dddd,	J	=	18.3,	12.1,	8.5,	6.3	Hz,	1H),	1.56	
(dd,	J	=	14.4,	12.5	Hz,	1H),	1.40	(q,	J	=	1.7	Hz,	3H),	1.35	(s,	3H),	1.26	(s,	3H),	1.21	(s,	3H).	13C	NMR	
(126	MHz,	CDCl3)	δ	ppm:	153.9,	137.8,	137.4,	133.7,	129.6,	128.6,	127.9,	127.9	117.7,	93.2,	91.4,	
78.4,	75.0,	70.4,	64.8,	58.8,	43.2,	39.2,	31.7,	30.3,	24.2,	24.2,	23.0,	22.6,	18.9,	15.7.	IR	(ν,	cm-1):	
3053,	 2980,	 2944,	 2834,	 1798,	 1466,	 1427,	 1265,	 1018.	HRMS	 (CI/ISO)	m/z:	 [M+H]+	Calcd	 for	
C28H35O6	467.2434,	found	467.2433.	[α]
25
D
:	+82.0	(c	1.0,	CHCl3).	
(1R,5S,6S,10S,10S,11S)-10-((benzyloxy)methoxy)-5-hydroxy-2,10,12,12-tetramethyl-
5,6,8,9,10,10,11,11-octahydro-4H-1,5-methanobenzo[4,5]cyclodeca[1,2]oxiren-6-yl	 benzoate	
(24).	To	a	solution	of	23	(20	mg,	43	µmol)	in	THF	(2	mL)	at	-78	°C	was	added	phenyllithium	(0.4	
mL,	2	M	in	nBu2O,	0.4	mmol,	10	equiv).	The	mixture	was	stirred	at	this	temperature	for	2	h.	A	
solution	 of	 saturated	 aqueous	 NaHCO3	 (5	 mL)	 was	 then	 added	 and	 the	 aqueous	 phase	 was	
extracted	with	Et2O	(3x10	mL).	The	combined	organic	extracts	were	washed	with	brine	(10	mL),	
dried	over	anhydrous	MgSO4,	 filtered	and	concentrated	 in	vacuo.	The	crude	mixture	was	then	
purified	by	 flash	 chromatography	 (petroleum	ether/Et2O:	 8/2)	 to	 afford	 the	 title	 benzoate	24	
(21	mg,	39	µmol,	92%)	as	a	colourless	oil.	1H	NMR	(400	MHz,	CDCl3)	δ	ppm:	8.10-8.05	(m,	2H),	
7.64-7.55	(m,	1H),	7.53-7.44	(m,	2H),	7.39-7.35	(m,	4H),	7.34-7.28	(m,	1H),	6.16	(dd,	J	=	5.8,	2.4	
Hz,	1H),	5.94	(s,	1H),	5.37	(tq,	J	=	3.3,	1.8	Hz,	1H),	4.93	(d,	J	=	7.2	Hz,	1H),	4.81	(d,	J	=	7.2	Hz,	1H),	
4.72	(d,	J	=	11.5	Hz,	1H),	4.64	(d,	J	=	11.5	Hz,	1H),	3.81	(dd,	J	=	10.5,	3.1	Hz,	1H),	3.08	(ddq,	J	=	
18.7,	3.3,	1.8	Hz,	1H),	2.81	(dd,	J	=	12.2,		4.4	Hz,	1H),	2.49	(dd,	J	=	14.2,	4.4	Hz,	1H),	2.23-2.09	(m,	
2H),	2.07	(s,	1H),	2.01-1.90	(m,	1H),	1.95	(dd,	J	=	14.2,	12.2	Hz,	1H),	1.89-1.80	(m,	1H),	1.69-1.56	
(m,	1H),	1.46	 (q,	 J	 =	1.8	Hz,	3H),	1.32	 (s,	3H),	1.28	 (s,	6H).	 13C	NMR	 (100	MHz,	CDCl3)	δ	ppm:	
165.7,	140.2,	137.6,	136.4,	133.1,	130.4,	129.7,	128.8,	128.5,	128.5,	127.9,	127.8,	120.9,	93.6,	
79.8,	78.7,	74.1,	70.1,	65.6,	60.3,	43.4,	41.0,	34.2,	33.1,	24.5,	24.1,	23.1,	22.0,	19.2,	16.0.	IR	(ν,	
cm-1):	 3050,	 2967,	 2939,	 2870,	 1721,	 1560,	 1468,	 1267,	 1115,	 1063.	HRMS	 (ESI/TOF-Q)	m/z:	
[M+Na]+	Calcd	for	C34H40O6Na	567.2717,	found	567.2697.	[α]
25
D
:	+226	(c	1.0,	CHCl3).	
(3S,7R,8S,9S,12S)-9-((Benzyloxy)methoxy)-6,8,13,13-tetramethyl-2-oxo-8,8,9,10,11,12-
hexahydro-3,7-methanobenzo[3,4]cyclonona[1,2][1,3]dioxole-7(4H)-carbaldehyde	 (25).	 To	 a	
solution	of	vinyl	epoxide	23	 (8.0	mg,	17	µmol)	 in	CH2Cl2	(0.5	mL)	were	added	allyl	alcohol	(3.5	
µL,	51	µmol,	3.0	equiv)	and	Sc(OTf)3	(2.0	mg,	4.3	µmol,	0.25	equiv).	The	mixture	was	stirred	at	
room	temperature	for	16	h.	A	solution	of	saturated	aqueous	NaHCO3	(2	mL)	was	then	added	and	
the	 aqueous	 phase	was	 extracted	with	 EtOAc	 (3x5	mL).	 The	 combined	 organic	 extracts	were	
washed	with	brine	 (10	mL),	dried	over	anhydrous	MgSO4,	 filtered	and	concentrated	 in	 vacuo.	
The	crude	mixture	was	then	purified	by	flash	chromatography	(petroleum	ether/EtOAc:	95/5	to	
85/15)	to	afford	the	title	aldehyde	25	(2.9	mg,	6.3	µmol,	37%)	as	a	colourless	oil.	1H	NMR	(500	
MHz,	CDCl3)	δ	ppm:	9.65	(s,	1H),	7.38-7.28	(m,	5H),	5.85	(dd,	J	=	3.9,	1.5	Hz,	1H),	5.55-5.45	(m,	
1H),	5.05	(s,	1H),	4.88	(d,	J	=	7.2	Hz,	1H),	4.77	(d,	J	=	7.2	Hz,	1H),	4.66	(d,	J	=	11.8	Hz,	1H),	4.63	(d,	
J	=	11.8	Hz,	1H),	3.42	(dd,	J	=	11.8,	3.9	Hz,	1H),	2.66	(d,	J	=	17.2	Hz,	1H),	2.49	(dd,	J	=	18.0,	3.1	Hz,	
1H),	2.35-2.29	(m,	1H),	2.27-2.19	(m,	1H),	2.07-1.94	(m,	2H),	1.76-1.70	(m,	1H),	1.69	(s,	3H),	1.60	
(d,	 J	=	17.2	Hz,	1H),	1.35	 (s,	3H),	1.21	 (s,	3H),	1.16	 (s,	3H).	 13C	NMR	 (126	MHz,	CDCl3)	δ	ppm:	
203.7,	153.7,	137.6,	132.9,	131.3,	128.4,	127.9,	127.7,	124.0,	121.6,	93.6,	88.0,	78.3,	78.2,	70.0,	
59.5,	 39.6,	 39.4,	 30.6,	 30.1,	 25.9,	 24.3,	 23.7,	 21.0,	 20.7,	 17.9.	 IR	 (ν,	 cm-1):	 3049,	 2989,	 2953,	
1801,	1717,	1632,	1446,	1425,	1345,	1267,	1190,	1026.	HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	
for	C28H34O6Na	489.2248,	found	489.2235.	[α]
20
D
:	+32.0	(c	0.75,	CHCl3).	
(1S,5S,6S,8S,11S,12S)-8-(Allyloxy)-1-((benzyloxy)methoxy)-6,11-dihydroxy-9,12,13,13-
tetramethyl-1,2,3,5,6,7,8,11,12,12-decahydro-6,10-methanobenzo[10]annulen-5-yl	 benzoate	
(26)	 and	 (1S,2S,3S,5R,6R,8S,11S)-3-((Benzyloxy)methoxy)-1,8-dihydroxy-2,9,9-trimethyl-10-
methylenedecahydro-1H-2,8:6,9-dimethanobenzoazulen-11-yl	 benzoate	 (27).	To	 a	 solution	 of	
vinyl	epoxide	24	(13	mg,	24	µmol)	in	allyl	alcohol	(0.5	mL)	was	added	Yb(OTf)3	(1.5	mg,	2.4	µmol,	
0.1	 equiv)	 The	 mixture	 was	 stirred	 at	 room	 temperature	 for	 16	 h.	 A	 solution	 of	 saturated	
aqueous	NaHCO3	(2	mL)	was	then	added	and	the	aqueous	phase	was	extracted	with	EtOAc	(3x5	
mL).	 The	 combined	 organic	 extracts	 were	 washed	 with	 brine	 (10	mL),	 dried	 over	 anhydrous	
MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	
chromatography	(CH2Cl2/EtOAc:	95/5)	to	afford	the	title	alcohol	26	(3.5	mg,	5.8	µmol,	24%)	and	
pentacycle	27	 (4.1	mg,	 7.4	 µmol,	 31%)	 as	 colourless	 oils.	 (1S,5S,6S,8S,11S,12S)-8-(Allyloxy)-1-
((benzyloxy)methoxy)-6,11-dihydroxy-9,12,13,13-tetramethyl-1,2,3,5,6,7,8,11,12,12-
decahydro-6,10-methanobenzo[10]annulen-5-yl	 benzoate	 (26).	 1H	 NMR	 (500	 MHz,	 CDCl3)	 δ	
ppm:	8.13-8.08	(m,	2H),	7.63-7.57	(m,	1H),	7.52-7.46	(m,	2H),	7.37-7.32	(m,	4H),	7.32-7.28	(m,	
1H),	6.11	(s,	1H),	5.98	(ddt,	J	=	17.3,	10.5,	5.4	Hz,	1H),	5.68	(t,	J	=	3.5	Hz,	1H),	5.34	(dq,	J	=	17.3,	
1.5	Hz,	1H),	5.22	(dq,	J	=	10.5,	1.5	Hz,	1H),	4.85	(d,	J	=	7.2	Hz,	1H),	4.76	(d,	J	=	7.2	Hz,	1H),	4.69	(d,	
J	=	11.6	Hz,	1H),	4.62	(d,	J	=	11.6	Hz,	1H),	4.60-4.56	(m,	2H),	4.14-4.02	(m,	2H),	3.44	(dd,	J	=	6.8,	
3.0	Hz,	1H),	2.81	(dd,	J	=	13.6,	6.7	Hz,	1H),	2.18-2.06	(m,	1H),	2.00-1.71	(m,	5H),	1.66	(s,	3H),	1.58	
(br.	s,	1H),	1.55	(dd,	J	=	13.6,	7.2	Hz,	1H),	1.48	(s,	3H),	1.44	(br.	s,	1H),	1.39	(s,	3H),	1.12	(s,	3H).	
1H	NMR	(500	MHz,	C6D6)	δ	ppm:	8.25	(dd,	J	=	1.4,	8.3	Hz,	2H),	7.33-7.25	(m,	3H),	7.10-7.04	(m,	
5H),	6.51	(s,	1H),	5.93	(ddt,	J	=	17.2,	10.4,	5.2	Hz,	1H),	5.71	(t,	J	=	3.3	Hz,	1H),	5.34	(dq,	J	=	17.2,	
1.8	Hz,	1H),	5.10	(dq,	J	=	10.4,	1.8	Hz,	1H),	4.65	(d,	J	=	7.1	Hz,	1H),	4.62	(dd,	J	=	6.9,	6.5	Hz,	1H),	
4.54	(d,	J	=	7.1	Hz,	1H),	4.53	(d,	J	=	12.1	Hz,	1H),	4.54-4.50	(m,	1H),	4.47	(d,	J	=	12.1	Hz,	1H),	4.00	
(ddt,	J	=	13.1,	5.2,	1.8	Hz,	1H),	3.91	(ddt,	J	=	13.1,	5.2,	1.8	Hz,	1H),	3.40	(dd,	J	=	7.9,	3.1	Hz,	1H),	
2.92	 (dd,	 J	=	13.7,	6.9	Hz,	1H),	2.04-1.92	 (m,	3H),	1.78	 (s,	3H),	1.73-1.66	 (m,	2H),	1.65	 (s,	3H),	
1.61	(dd,	J	=	13.7,	6.5	Hz,	1H),	1.61-1.57	(m,	1H),	1.46	(s,	3H),	1.35-1.29	(m,	2H),	1.14	(s,	3H).	13C	
NMR	 (126	MHz,	CDCl3)	 δ	 ppm:	 164.6,	 145.6,	 141.7,	 137.9,	 135.4,	 133.0,	 130.6,	 129.5,	 128.5,	
128.4,	128.1,	127.8,	127.7,	117.3,	116.6,	94.0,	91.2,	84.0,	79.7,	72.3,	70.8,	70.1,	69.9,	65.3,	43.0,	
41.5,	 32.9,	 25.6,	 24.8	 	 22.6,	 22.2,	 21.9,	 10.9.	HRMS	 (ESI/TOF-Q)	m/z:	 [M+Na-H2O]
+	 Calcd	 for	
C37H44O6Na	607.3030,	found	607.3020.	[α]
22
D
:	-36.0	(c	0.5,	CHCl3).	(1S,2S,3S,5R,6R,8S,11S)-3-
((Benzyloxy)methoxy)-1,8-dihydroxy-2,9,9-trimethyl-10-methylenedecahydro-1H-2,8:6,9-
dimethanobenzoazulen-11-yl	benzoate	(27).	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	8.09	(dd,	J	=	8.3,	
1.2	Hz,	2H,	HAr),	7.65-7.59	(m,	1H,	HAr),	7.53-7.46	(m,	2H,	HAr),	7.39-7.34	(m,	4H,	HAr),	7.33-7.29	
(m,	1H,	HAr),	6.00	(d,	J	=	1.7	Hz,	1H,	H2),	4.87	(s,	1H,	H18),	4.85	(d,	J	=	7.1	Hz,	1H,	Ha),	4.81	(s,	1H,	
H18),	4.74	(d,	J	=	7.1	Hz,	1H,	Ha),	4.70	(d,	J	=	12.1	Hz,	1H,	Hb),	4.61	(d,	J	=	12.1	Hz,	1H,	Hb),	4.48	
(dd,	J	=	12.0,	6.0	Hz,	1H,	H10),	3.29	(dd,	J	=	11.8,	3.0	Hz,	1H,	H7),	2.73	(s,	1H,	OH),	2.58	(dd,	J	=	
12.1,	6.9	Hz,	1H,	H4),	2.42	(t,	J	=	2.8	Hz,	1H,	H13),	2.27	(dd,	J	=	12.0,	6.0	Hz,	1H,	H9),	1.99	(t,	J	=	
12.0	Hz,	1H,	H9),	1.91	(ddd,	J	=	12.7,	2.8,	1.7	Hz,	1H,	H14),	1.81	(dd,	J	=	12.7,	2.8	Hz,	1H,	H14),	
1.76-1.66	(m,	2H,	H5,	H6),	1.55	(s,	3H,	H17),	1.37-1.28	(m,	1H,	H6),	1.25	(br	s,	1H,	OH),	1.21-1.14	
(m,	1H,	H5),	0.99	(s,	3H,	H16),	0.99	(s,	3H,	H19).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	167.7	(COPh),	
157.5	(C12),	137.9	(CAr),	133.4	(CAr),	129.9	(CAr),	129.7	(CAr),	128.6	(CAr),	128.5	(CAr),	127.7	(CAr),	
127.6	 (CAr),	 103.5	 (C18),	 93.5	 (Ca),	 81.7	 (C7),	 80.5	 (C2),	 80.0	 (C1),	 75.8	 (C10),	 69.6	 (Cb),	 63.6	
(C11),	62.4	(C3),	50.9	(C15),	49.6	(C8),	45.1	(C13),	42.4	(C9),	39.0	(C4),	35.1	(C14),	26.0	(C5),	24.9	
(C6),	21.8	(C16),	21.0	(C17),	14.8	(C19).	IR	(ν,	cm-1):	3321,	3034,	2965,	2929,	1733,	1698,	1565,	
1463,	 1267,	 1113.	HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C34H40O6Na	 567.2717,	 found	
567.2706.	[α]
23
D
:	-38.0	(c	0.5,	CHCl3).	
(1R,3S,6S,10S,10S,11S)-10-((Benzyloxy)methoxy)-1,10,12,12-tetramethyl-1,2,6,8,10,10,11,11-
octahydro-3H,9H-1,3-
methanobenzo[3,4]bis(oxireno)[2',3':6,7;2'',3'':8,9]cyclodeca[1,2][1,3]dioxol-5-one	 (trans-28)	
and	(cis-28).	To	a	solution	of	triene	19f	(50	mg,	0.11	mmol)	in	CH2Cl2	(3	mL)	was	added	at	0	°C	a	
solution	of	mCPBA	 (76	mg,	0.33	mmol,	3.0	equiv)	 in	CH2Cl2	 (1	mL).	The	 resulting	mixture	was	
stirred	at	 room	temperature	 for	16	h.	The	 reaction	mixture	was	washed	with	a	10%	aqueous	
solution	 of	 Na2SO3	 (2x2	 mL)	 and	 the	 aqueous	 layer	 was	 extracted	 with	 CH2Cl2	 (10	 mL).	 The	
combined	organic	extracts	were	washed	with	a	saturated	aqueous	solution	of	NaHCO3	(10	mL)	
washed	with	brine	(10	mL)	and	dried	over	MgSO4,	filtered	and	concentrated	in	vacuo.	The	crude	
mixture	was	 then	purified	by	 flash	chromatography	 (petroleum	ether/Et2O:	6/4)	 to	afford	 the	
title	epoxide	trans-28	(37	mg,	77	µmol,	70%)	and	the	epoxide	cis-28	(3.2	mg,	6.6	µmol,	6%)	as	
colourless	 oils.	 (1R,1S,2S,3S,6S,10S,10S,11S)-10-((Benzyloxy)methoxy)-1b,10,12,12-
tetramethyl-1b,2,6,8,10,10,11,11-octahydro-3H,9H-1,3-
methanobenzo[3,4]bis(oxireno)[2',3':6,7;2'',3'':8,9]cyclodeca[1,2][1,3]dioxol-5-one	 (trans-28).	
1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	7.40-7.34	(m,	4H),	7.33-7.28	(m,	1H),	6.04	(dd,	J	=	4.9,	2.5	Hz,	
1H),	4.97	(s,	1H),	4.96	(d,	J	=	7.1	Hz,	1H),	4.83	(d,	J	=	7.1	Hz,	1H),	4.74	(d,	J	=	11.6	Hz,	1H),	4.65	(d,	
J	=	11.6	Hz,	1H),	4.03	(dd,	J	=	12.1,	3.9	Hz,	1H),	3.26	(d,	J	=	4.8	Hz,	1H),	3.05	(dd,	J	=	12.5,	4.1	Hz,	
1H),	3.04	(d,	J	=	16.6	Hz,	1H),	2.66	(dd,	J	=	14.7,	4.1	Hz,	1H),	2.36-2.21	(m,	2H),	2.12	(dd,	J	=	16.6,	
4.8	Hz,	1H),	2.06-1.99	(m,	1H),	1.77	(qd,	J	=	12.1,	6.9	Hz,	1H),	1.38	(s,	3H),	1.37	(m,	J	=	14.7,	12.5	
Hz,	1H),	1.19	(s,	6H),	1.16	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	153.4,	137.6,	132.4,	130.8,	
128.5,	 127.8,	 127.8,	 93.4,	 91.4,	 78.6,	 75.1,	 70.2,	 65.1,	 60.4,	 60.1,	 59.3,	 42.8,	 39.7,	 30.8,	 28.4,	
24.0,	23.5,	23.4,	22.8,	19.0,	16.7.	IR	(ν,	cm-1):	3049,	2987,	2958,	1801,	1684,	1543,	1400,	1214,	
1093.	HRMS	(CI/ISO)	m/z:	[M+H]+	Calcd	for	C28H35O7	483.2383,	found	483.2379.	[α]
21
D
:	+70.0	
(c	 1.0,	 CHCl3).	 (1R,1R,2R,3S,6S,10S,10S,11S)-10-((Benzyloxy)methoxy)-1,10,12,12-tetramethyl-
1,2,6,8,10,10,11,11-octahydro-3H,9H-1,3-methanobenzo	
[3,4]bis(oxireno)[2',3':6,7;2'',3'':8,9]cyclodeca[1,2][1,3]dioxol-5-one	 (cis-28).	 1H	 NMR	 (500	
MHz,	CDCl3)	δ	ppm:	7.37-7.34	(m,	4H),	7.32-7.28	(m,	1H),	5.76	(t,	J	=	3.5	Hz,	1H),	5.09	(s,	1H),	
4.93	(d,	J	=	7.0	Hz,	1H),	4.83	(d,	J	=	7.0	Hz,	1H),	4.74	(d,	J	=	11.8	Hz,	1H),	4.67	(d,	J	=	11.8	Hz,	1H),	
3.80	(dd,	J	=	11.9,	4.5	Hz,	1H),	3.48	(d,	J	=	3.4	Hz,	1H),	2.96	(dd,	J	=	7.8,	6.5	Hz,	1H),	2.76	(dd,	J	=	
15.2,	6.5	Hz,	1H),	2.38	(d,	J	=	15.4	Hz,	1H),	2.36-2.31	(m,	2H),	2.07	(dd,	J	=	15.4,	3.4	Hz,	1H),	2.07-
2.01	(m,	1H),	1.85-1.74	(m,	1H),	1.71	(s,	3H),	1.53	(s,	3H),	1.11	(dd,	J	=	15.2,	7.8,	1H),	1.08	(s,	3H),	
1.02	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	149.3,	137.6,	134.4,	128.5,	127.8,	127.6,	126.8,	
93.5,	87.5,	75.7,	73.4,	70.0,	68.2,	64.3,	62.4,	55.5,	55.2,	42.6,	33.7,	28.4,	26.4,	24.8,	23.3,	23.1,	
22.9,	12.5.	HRMS	(EI)	m/z:	[M]+	Calcd	for	C28H34O7	482.2305,	found	482.2307.	[α]
25
D
:	+59.0	(c	
0.75,	CHCl3).	
(3S,5S,8S,9S,10S,13S)-10-((Benzyloxy)methoxy)-5,8-dihydroxy-6,9,14,14-tetramethyl-
5,8,9,9,10,11,12,13b-octahydro-4H-3,7-methanobenzo[3,4]cyclodeca[1,2][1,3]dioxol-2-one	
(29).	 Zinc	 dust	 (0.20	 g,	 3.0	mmol)	 was	 added	 to	 a	 solution	 of	 Cp2TiCl2	 (0.25	 g,	 1.0	mmol)	 in	
anhydrous	and	degassed	THF	(2.5	mL).	The	suspension	was	vigorously	stirred	for	2	h.	The	freshly	
made	green	solution	of	[Cp2TiCl]2	(0.83	mL,	0.2	M	in	THF,	0.16	mmol,	5	equiv)	was	added	to	a	
solution	 of	 diepoxide	 trans-28	 (16	mg,	 33	 µmol)	 in	 THF	 (1.5	mL).	 The	 resulting	mixture	 was	
stirred	 at	 reflux	 for	 16	 h.	 A	 1N	 aqueous	 solution	 of	 HCl	 (5	mL)	was	 added	 and	 the	 resulting	
mixture	was	stirred	for	5	min.	The	aqueous	layer	was	extracted	with	EtOAc	(3x10	mL),	drier	over	
MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	
chromatography	 (petroleum	ether/EtOAc:	3/7)	 to	afford	 the	 title	1,4-diol	29	 (3	mg,	6.3	µmol,	
19%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	7.42-7.35	(m,	4H),	7.34-7.29	(m,	1H),	
5.65	(t,	J	=	3.3	Hz,	1H),	5.47	(s,	1H),	4.91	(d,	J	=	7.3	Hz,	1H),	4.79	(d,	J	=	7.3	Hz,	1H),	4.78	(d,	J	=	
11.9	Hz,	1H),	4.66	(d,	J	=	11.9	Hz,	1H),	4.67-4.63	(m,	1H),	4.59	(dd,	J	=	11.6,	6.1	Hz,	1H),	3.41	(dd,	
J	=	11.8,	4.6	Hz,	1H),	2.32	(dd,	J	=	14.6,	6.1	Hz,	1H),	2.35-2.27	(m,	1H),	2.24	(dd,	J	=	13.3,	6.5	Hz,	
1H),	2.25-2.15	(m,	1H),	1.98-1.94	(m,	1H),	1.83-1.78	(m,	1H),	1.79	(s,	3H),	1.78	(dd,	J	=	13.3,	7.8	
Hz,	1H),	1.68	(dd,	J	=	14.6,	11.6	Hz,	1H),	1.61	(s,	3H),	1.43	(s,	1H),	1.32	(s,	3H),	1.15	(s,	3H),	1.11	
(br	 s,	 1H).	 13C	NMR	 (126	MHz,	CDCl3)	 δ	ppm:	150.5,	 150.4,	 137.9,	 135.2,	 135.2,	 128.5,	 127.9,	
127.2,	123.2,	93.3,	92.1,	76.1,	75.3,	73.8,	70.0,	63.5,	59.9,	39.9,	39.3,	37.2,	26.9,	25.4,	24.2,	23.1,	
22.8,	11.5.	IR	(ν,	cm-1):	3366,	3054,	2986,	2927,	1744,	1543,	1427,	1280.	HRMS	(ESI/TOF-Q)	m/z:	
[M+Na]+	Calcd	for	C28H36O7Na	507.2353,	found	507.2332.	[α]
21
D
:	+43.0	(c	0.75,	CHCl3).	
(1R,1S,2S,4S,5S,9S,9S,10S)-9-((Benzyloxy)methoxy)-4-hydroxy-1,9,11,11-tetramethyl-
1,2,4,5,7,8,9,9,10,10-decahydro-3H-1,4-methanobenzo[6,7]cyclodeca[1,2:3,4]bis(oxirene)-5-yl	
benzoate	(30).	To	a	solution	of	diepoxide	trans-28	 (25	mg,	51	µmol)	 in	THF	(2.5	mL)	at	 -78	°C	
was	 added	 phenyllithium	 (0.22	 mL,	 2	 M	 in	 nBu2O,	 0.45	 mmol,	 9.0	 equiv).	 The	 mixture	 was	
stirred	at	 this	 temperature	 for	2	h.	A	 solution	of	 saturated	aqueous	NaHCO3	 (2	mL)	was	 then	
added	and	the	aqueous	phase	was	extracted	with	Et2O	(3x5	mL).	The	combined	organic	extracts	
were	 washed	with	 brine	 (10	mL),	 dried	 over	 anhydrous	MgSO4,	 filtered	 and	 concentrated	 in	
vacuo.	 The	 crude	mixture	was	 then	purified	 by	 flash	 chromatography	 (petroleum	ether/Et2O:	
7/3)	to	afford	the	title	benzoate	30	(23	mg,	41	µmol,	80%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	
CDCl3)	δ	ppm:	8.08-8.02	(m,	2H),	7.64-7.57	(m,	1H),	7.52-7.44	(m,	2H),	7.40-7.35	(m,	4H),	7.33-
7.28	(m,	1H),	6.13	(dd,	J	=	5.5,	2.5	Hz,	1H),	5.75	(s,	1H),	4.95	(d,	J	=	7.1	Hz,	1H),	4.83	(d,	J	=	7.1	Hz,	
1H),	4.75	(d,	J	=	11.7	Hz,	1H),	4.66	(d,	J	=	11.7	Hz,	1H),	3.96	(dd,	J	=	11.4,	3.4	Hz,	1H),	3.22	(d,	J	=	
4.6	Hz,	1H),	3.14	(dd,	J	=	12.0,	4.1	Hz,	1H),	3.12	(d,	J	=	16.6	Hz,	1H),	2.48	(dd,	J	=	14.4,	4.1	Hz,	1H),	
2.34	(s,	1H),	2.26-2.13	(m,	2H),	2.01	(dd,	J	=	16.6,	4.6	Hz,	1H),	1.89	(ddt,	J	=	11.4,	5.6,	2.8	Hz,	1H),	
1.70-1.60	(m,	1H),	1.64	(dd,	J	=	14.4,	12.0	Hz,	1H),	1.31	(s,	3H),	1.26	(s,	3H),	1.21	(s,	6H).	13C	NMR	
(126	MHz,	CDCl3)	δ	ppm:	165.4,	138.0,	137.7,	133.2,	131.1,	130.2,	129.7,	128.5,	128.5,	127.9,	
127.7,	93.6,	79.8,	77.6,	74.4,	70.1,	64.3,	61.1,	60.2,	59.9,	42.9,	41.4,	31.5,	31.3,	24.2,	23.6,	23.0,	
22.6,	19.2,	17.7.	IR	(ν,	cm-1):	3054,	2986,	1717,	1520,	1421,	1265,	1020.	HRMS	(ESI/TOF-Q)	m/z:	
[M+Na]+	Calcd	for	C34H40O7Na		583.2666,	found	583.2652.	[α]
25
D
:	+28.0	(c	1.0,	CHCl3).	
(1S,5S,6S,8S,11S,12S)-1-((Benzyloxy)methoxy)-6,8,11-trihydroxy-9,12,13,13-tetramethyl-
1,2,3,5,6,7,8,11,12,12-decahydro-6,10-methanobenzo[10]annulen-5-yl	benzoate	(31).	Zinc	dust	
(0.20	 g,	 3.0	mmol)	was	 added	 to	 a	 solution	 of	 Cp2TiCl2	 (0.25	 g,	 1.0	mmol)	 in	 anhydrous	 and	
degassed	THF	(2.5	mL).	The	suspension	was	vigorously	stirred	for	2	h.	The	freshly	made	green	
solution	of	[Cp2TiCl]2	(0.93	mL,	0.2	M	in	THF,	0.19	mmol,	5.0	equiv)	was	added	to	a	solution	of	
diepoxide	 30	 (21	 mg,	 37	 µmol)	 in	 THF	 (1.5	 mL).	 The	 resulting	 mixture	 was	 stirred	 at	 room	
temperature	for	4	h.	A	1N	aqueous	solution	of	HCl	(5	mL)	was	added	and	the	resulting	mixture	
was	stirred	for	5	min.	The	aqueous	layer	was	extracted	with	EtOAc	(3x10	mL),	drier	over	MgSO4,	
filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	 mixture	 was	 then	 purified	 by	 flash	
chromatography	(petroleum	ether/EtOAc:	3/7)	to	afford	the	title	1,4-diol	31	 (11	mg,	20	µmol,	
53%)	as	a	colourless	oil.	1H	NMR	(500	MHz,	CDCl3)	δ	ppm:	8.09-8.03	(m,	2H),	7.62-7.56	(m,	1H),	
7.50-7.44	 (m,	2H),	7.44-7.36	 (m,	4H),	7.34-7.28	 (m,	1H),	5.90	 (dd,	 J	=	4.9,	2.5	Hz,	1H),	5.70	 (s,	
1H),	5.08	(dd,	J	=	11.8,	5.2	Hz,	1H),	4.98	(d,	J	=	7.3	Hz,	1H),	4.87	(d,	J	=	12.2	Hz,	1H),	4.82	(d,	J	=	
7.3	Hz,	1H),	4.68	(d,	J	=	12.2	Hz,	1H),	4.61-4.53	(m,	1H),	3.86	(dd,	J	=	12.2,	3.9	Hz,	1H),	2.50-2.46	
(m,	2H),	2.36	(dd,	J	=	14.5,	5.2	Hz,	1H),	2.28	(s,	1H),	2.23-2.15	(m,	2H),	2.14-2.09	(m,	2H),	1.96-
1.89	(m,	1H),	1.84	(d,	J	=	1.1	Hz,	3H),	1.70-1.63	(m,	1H),	1.65	(s,	3H),	1.57	(br	s,	1H),	1.17	(s,	3H),	
1.07	(s,	3H).	13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	165.5,	144.8,	138.0,	137.1,	136.3,	133.1,	130.3,	
129.7,	128.5,	128.5,	127.7,	127.2,	123.4,	93.1,	79.3,	75.5,	74.1,	70.0,	69.2,	67.7,	42.6,	41.4,	38.5,	
38.2,	28.2,	24.2,	23.9,	22.8,	19.9,	16.8.	HRMS	(ESI/TOF-Q)	m/z:	[M+Na]+	Calcd	for	C34H42O7Na	
585.2823,	found	585.2808.	[α]
21
D
:	+60.0	(c	1.0,	CHCl3).	
(1S,5S,6S,8S,11S,12S)-1-((Benzyloxy)methoxy)-6,8-dihydroxy-9,12,13,13-tetramethyl-11-
((triethylsilyl)oxy)-1,2,3,5,6,7,8,11,12,12-decahydro-6,10-methanobenzo[10]annulen-5-yl	
benzoate	(32).To	a	solution	of	diol	31	(6.7	mg,	12	µmol)	in	CH2Cl2	(1	mL)	were	added	imidazole	
(8.2	mg,	0.12	mmol,	10	equiv)	and	TESCl	 (10	µL,	60	µmol,	5	equiv).	The	 reaction	mixture	was	
stirred	 for	 16	 h.	 A	 saturated	 aqueous	 solution	 of	 NaHCO3	 (1	 mL)	 was	 added	 to	 quench	 the	
reaction.	 The	 aqueous	 layer	 was	 extracted	 with	 CH2Cl2	 (3x5	 mL),	 and	 the	 combined	 organic	
extracts	 were	 dried	 over	 anhydrous	 MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	 crude	
mixture	was	then	purified	by	flash	chromatography	(petroleum	ether/Et2O:	65/35)	to	afford	the	
title	mono	protected	alcohol	32	(5.5	mg,	8.2	µmol,	68%)	as	a	colourless	oil.1H	NMR	(500	MHz,	
CDCl3)	δ	ppm:	8.08-8.04	(m,	2H),	7.61-7.54	(m,	1H),	7.50-7.44	(m,	2H),	7.39-7.34	(m,	4H),	7.33-
7.28	(m,	1H),	5.88	(dd,	J	=	5.8,	2.3	Hz,	1H),	5.72	(s,	1H),	4.99	(d,	J	=	6.7	Hz,	1H),	4.96	(dd,	J	=	11.4,	
5.7	Hz,	1H),	4.90	(d,	J	=	6.7	Hz,	1H),	4.79	(d,	J	=	11.8	Hz,	1H),	4.59-4.54	(m,	1H),	4.53	(d,	J	=	11.8	
Hz,	1H),	3.75	(dd,	J	=	12.2,	4.0	Hz,	1H),	2.48	(d,	J	=	6.7	Hz,	2H),	2.27-2.18	(m,	1H),	2.23	(dd,	J	=	
15.0,	5.7	Hz,	1H),	2.17-2.09	(m,	3H),	2.08	(s,	1H),	1.86	(d,	J	=	1.0	Hz,	3H),	1.81-1.71	(m,	1H),	1.69	
(s,	3H),	1.54	(br	s,	1H),	1.14	(s,	3H),	1.07	(s,	3H),	0.97	(t,	J	=	8.0	Hz,	9H),	0.60	(d,	J	=	8.0	Hz,	6H).	
13C	NMR	(126	MHz,	CDCl3)	δ	ppm:	165.6,	145.2,	137.8,	136.9,	134.9,	133.1,	130.4,	129.7,	128.5,	
128.5,	127.8,	127.7,	122.9,	95.8,	79.4,	78.9,	74.1,	69.6,	69.2,	68.0,	42.8,	41.5,	39.4,	38.5,	27.9,	
24.5,	 24.4,	 23.9,	 19.7,	 16.8,	 6.9,	 4.9.	 IR	 (ν,	 cm-1):	 3421,	 3049,	 2984,	 2961,	 2882,	 1717,	 1675,	
1430,	 1409,	 1206,	 1095,	 1005.	 HRMS	 (ESI/TOF-Q)	 m/z:	 [M+Na]+	 Calcd	 for	 C40H56O7SiNa	
699.3688,	found	699.3653.	[α]
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:	+10.0	(c	0.75,	CHCl3).	
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